{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:17:27Z","timestamp":1795015047609,"version":"4.9.1"},"reference-count":248,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Peripheral inflammation could constitute a risk factor for AD. This review summarizes the research related to peripheral inflammation that appears to have a relationship with Alzheimer\u2019s disease. We find there are significant associations between AD and peripheral infection induced by various pathogens, including herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, <jats:italic>Porphyromonas gingivalis<\/jats:italic>, <jats:italic>Helicobacter pylori<\/jats:italic>, and <jats:italic>Toxoplasma gondii<\/jats:italic>. Chronic inflammatory diseases are also reported to contribute to the pathophysiology of AD. The mechanisms by which peripheral inflammation affects the pathophysiology of AD are complex. Pathogen-derived neurotoxic molecule composition, disrupted BBB, and dysfunctional neurogenesis may all play a role in peripheral inflammation, promoting the development of AD. Anti-pathogenic medications and anti-inflammatory treatments are reported to decrease the risk of AD. Studies that could improve understanding the associations between AD and peripheral inflammation are needed. If our assumption is correct, early intervention against inflammation may be a potential method of preventing and treating AD.<\/jats:p>","DOI":"10.1515\/revneuro-2023-0049","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T12:11:08Z","timestamp":1692619868000},"page":"99-120","source":"Crossref","is-referenced-by-count":23,"title":["Peripheral inflammation is a potential etiological factor in Alzheimer\u2019s disease"],"prefix":"10.1515","volume":"35","author":[{"given":"Ziyuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine , Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Kongjiang Road 1665, Yangpu District , Shanghai 200092 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine , Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Kongjiang Road 1665, Yangpu District , Shanghai 200092 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-6655","authenticated-orcid":false,"given":"Yafu","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine , Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Kongjiang Road 1665, Yangpu District , Shanghai 200092 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"2024080910403062789_j_revneuro-2023-0049_ref_001","doi-asserted-by":"crossref","unstructured":"Acu\u00f1a, L., Hamadat, S., Corbal\u00e1n, N.S., Gonz\u00e1lez-Liz\u00e1rraga, F., Dos-Santos-Pereira, M., Rocca, J., D\u00edaz, J.S., Del-Bel, E., Papy-Garc\u00eda, D., Cheh\u00edn, R.N., et al. (2019). Rifampicin and its derivative rifampicin quinone reduce microglial inflammatory responses and neurodegeneration induced in vitro by \u03b1-synuclein aggregates. Cells 8: 766, https:\/\/doi.org\/10.3390\/cells8080776.","DOI":"10.3390\/cells8080776"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_002","doi-asserted-by":"crossref","unstructured":"Aisen, P.S., Schmeidler, J., and Pasinetti, G.M. (2002). Randomized pilot study of nimesulide treatment in Alzheimer\u2019s disease. Neurology 58: 1050\u20131054, https:\/\/doi.org\/10.1212\/wnl.58.7.1050.","DOI":"10.1212\/WNL.58.7.1050"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_003","doi-asserted-by":"crossref","unstructured":"Aksenov, M.Y., Aksenova, M.V., Mactutus, C.F., and Booze, R.M. (2010). HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci. Lett. 475: 174\u2013178, https:\/\/doi.org\/10.1016\/j.neulet.2010.03.073.","DOI":"10.1016\/j.neulet.2010.03.073"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_004","doi-asserted-by":"crossref","unstructured":"Aktas, O., Ullrich, O., Infante-Duarte, C., Nitsch, R., and Zipp, F. (2007). Neuronal damage in brain inflammation. Arch. Neurol. 64: 185\u2013189, https:\/\/doi.org\/10.1001\/archneur.64.2.185.","DOI":"10.1001\/archneur.64.2.185"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_005","doi-asserted-by":"crossref","unstructured":"Albornoz, E.A., Woodruff, T.M., and Gordon, R. (2018). Inflammasomes in CNS diseases. Exper. Suppl. 108: 41\u201360, https:\/\/doi.org\/10.1007\/978-3-319-89390-7_3.","DOI":"10.1007\/978-3-319-89390-7_3"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_006","doi-asserted-by":"crossref","unstructured":"Alexaki, V.I. (2021). The impact of obesity on microglial function: immune, metabolic and endocrine perspectives. Cells 10: 1584, https:\/\/doi.org\/10.3390\/cells10071584.","DOI":"10.3390\/cells10071584"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_007","doi-asserted-by":"crossref","unstructured":"Alonso, R., Pisa, D., Fern\u00e1ndez-Fern\u00e1ndez, A.M., and Carrasco, L. (2018). Infection of fungi and bacteria in brain tissue from elderly persons and patients with Alzheimer\u2019s disease. Front. Aging Neurosci. 10: 159, https:\/\/doi.org\/10.3389\/fnagi.2018.00159.","DOI":"10.3389\/fnagi.2018.00159"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_008","doi-asserted-by":"crossref","unstructured":"Alonso, R., Pisa, D., Marina, A.I., Morato, E., R\u00e1bano, A., and Carrasco, L. (2014). Fungal infection in patients with Alzheimer\u2019s disease. J.\u00a0Alzheimer\u2019s Dis. 41: 301\u2013311, https:\/\/doi.org\/10.3233\/jad-132681.","DOI":"10.3233\/JAD-132681"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_009","doi-asserted-by":"crossref","unstructured":"Arnst, N., Redolfi, N., Lia, A., Bedetta, M., Greotti, E., and Pizzo, P. (2022). Mitochondrial Ca2+ signaling and bioenergetics in Alzheimer\u2019s disease. Biomedicines 10: 3025, https:\/\/doi.org\/10.3390\/biomedicines10123025.","DOI":"10.3390\/biomedicines10123025"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_010","doi-asserted-by":"crossref","unstructured":"Ashraf, G.M., Tarasov, V.V., Makhmutov\u0430, A., Chubarev, V.N., Avila-Rodriguez, M., Bachurin, S.O., and Aliev, G. (2019). The possibility of an infectious etiology of Alzheimer disease. Mol. Neurobiol. 56: 4479\u20134491, https:\/\/doi.org\/10.1007\/s12035-018-1388-y.","DOI":"10.1007\/s12035-018-1388-y"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_011","doi-asserted-by":"crossref","unstructured":"Atri, A. (2019). The Alzheimer\u2019s disease clinical spectrum: diagnosis and management. Med. Clin. North Am. 103: 263\u2013293, https:\/\/doi.org\/10.1016\/j.mcna.2018.10.009.","DOI":"10.1016\/j.mcna.2018.10.009"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_012","doi-asserted-by":"crossref","unstructured":"Bakota, L. and Brandt, R. (2016). Tau biology and tau-directed therapies for Alzheimer\u2019s disease. Drugs 76: 301\u2013313, https:\/\/doi.org\/10.1007\/s40265-015-0529-0.","DOI":"10.1007\/s40265-015-0529-0"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_013","doi-asserted-by":"crossref","unstructured":"Balducci, C. and Forloni, G. (2019). Doxycycline for Alzheimer\u2019s disease: fighting \u03b2-amyloid oligomers and neuroinflammation. Front. Pharmacol. 10: 738, https:\/\/doi.org\/10.3389\/fphar.2019.00738.","DOI":"10.3389\/fphar.2019.00738"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_014","doi-asserted-by":"crossref","unstructured":"Balducci, C., Santamaria, G., La Vitola, P., Brandi, E., Grandi, F., Viscomi, A.R., Beeg, M., Gobbi, M., Salmona, M., Ottonello, S., et al.. (2018). Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models. Neurobiol. Aging 70: 128\u2013139, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.002.","DOI":"10.1016\/j.neurobiolaging.2018.06.002"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_015","doi-asserted-by":"crossref","unstructured":"Baptista, P. and Andrade, J.P. (2018). Adult hippocampal neurogenesis: regulation and possible functional and clinical correlates. Front. Neuroanat. 12: 44, https:\/\/doi.org\/10.3389\/fnana.2018.00044.","DOI":"10.3389\/fnana.2018.00044"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_016","doi-asserted-by":"crossref","unstructured":"Barichello, T., Generoso, J.S., Collodel, A., Petronilho, F., and Dal-Pizzol, F. (2021). The blood-brain barrier dysfunction in sepsis. Tissue Barriers 9: 1840912, https:\/\/doi.org\/10.1080\/21688370.2020.1840912.","DOI":"10.1080\/21688370.2020.1840912"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_017","doi-asserted-by":"crossref","unstructured":"Barnes, P.J. (2014). Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin. Chest Med. 35: 71\u201386, https:\/\/doi.org\/10.1016\/j.ccm.2013.10.004.","DOI":"10.1016\/j.ccm.2013.10.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_018","doi-asserted-by":"crossref","unstructured":"Behairi, N., Belkhelfa, M., Rafa, H., Labsi, M., Deghbar, N., Bouzid, N., Mesbah-Amroun, H., and Touil-Boukoffa, C. (2016). All-trans retinoic acid (ATRA) prevents lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment in aged rats. J.\u00a0Neuroimmunol. 300: 21\u201329, https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.004.","DOI":"10.1016\/j.jneuroim.2016.10.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_019","doi-asserted-by":"crossref","unstructured":"Belarbi, K., Cuvelier, E., Bonte, M.A., Desplanque, M., Gressier, B., Devos, D., and Chartier-Harlin, M.C. (2020). Glycosphingolipids and neuroinflammation in Parkinson\u2019s disease. Mol. Neurodegener. 15: 59, https:\/\/doi.org\/10.1186\/s13024-020-00408-1.","DOI":"10.1186\/s13024-020-00408-1"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_020","doi-asserted-by":"crossref","unstructured":"Ben Haij, N., Plan\u00e8s, R., Leghmari, K., Serrero, M., Delobel, P., Izopet, J., BenMohamed, L., and Bahraoui, E. (2015). HIV-1 Tat protein induces production of proinflammatory cytokines by human dendritic cells and monocytes\/macrophages through engagement of TLR4-MD2-CD14 complex and activation of NF-\u03baB pathway. PLoS One 10: e0129425, https:\/\/doi.org\/10.1371\/journal.pone.0129425.","DOI":"10.1371\/journal.pone.0129425"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_021","doi-asserted-by":"crossref","unstructured":"Bermejo, P., Mart\u00edn-Arag\u00f3n, S., Bened\u00ed, J., Sus\u00edn, C., Felici, E., Gil, P., Ribera, J.M., and Villar, A.M. (2008). Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer\u2019s disease. Immunol. Lett. 117: 198\u2013202, https:\/\/doi.org\/10.1016\/j.imlet.2008.02.002.","DOI":"10.1016\/j.imlet.2008.02.002"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_022","doi-asserted-by":"crossref","unstructured":"Bertrand, L., Cho, H.J., and Toborek, M. (2019). Blood-brain barrier pericytes as a target for HIV-1 infection. Brain 142: 502\u2013511, https:\/\/doi.org\/10.1093\/brain\/awy339.","DOI":"10.1093\/brain\/awy339"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_023","doi-asserted-by":"crossref","unstructured":"Beydoun, M.A., Beydoun, H.A., Shroff, M.R., Kitner-Triolo, M.H., and Zonderman, A.B. (2013). Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosom. Med. 75: 486\u2013496, https:\/\/doi.org\/10.1097\/psy.0b013e31829108c3.","DOI":"10.1097\/PSY.0b013e31829108c3"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_024","doi-asserted-by":"crossref","unstructured":"Beydoun, M.A., Beydoun, H.A., Elbejjani, M., Dore, G.A., and Zonderman, A.B. (2018). Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer\u2019s disease dementia in large national surveys. Alzheimer\u2019s Dementia 14: 1148\u20131158, https:\/\/doi.org\/10.1016\/j.jalz.2018.04.009.","DOI":"10.1016\/j.jalz.2018.04.009"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_025","doi-asserted-by":"crossref","unstructured":"Bottari, N.B., Schetinger, M.R.C., Pillat, M.M., Palma, T.V., Ulrich, H., Alves, M.S., Morsch, V.M., Melazzo, C., de Barros, L.D., Garcia, J.L., et al.. (2019). Resveratrol as a therapy to restore neurogliogenesis of neural progenitor cells infected by Toxoplasma gondii. Mol. Neurobiol. 56: 2328\u20132338, https:\/\/doi.org\/10.1007\/s12035-018-1180-z.","DOI":"10.1007\/s12035-018-1180-z"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_026","doi-asserted-by":"crossref","unstructured":"Bourgade, K., Le Page, A., Bocti, C., Witkowski, J.M., Dupuis, G., Frost, E.H., and F\u00fcl\u00f6p, T.Jr. (2016). Protective effect of amyloid-\u03b2 peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J.\u00a0Alzheimer\u2019s Dis. 50: 1227\u20131241, https:\/\/doi.org\/10.3233\/jad-150652.","DOI":"10.3233\/JAD-150652"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_027","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z. and Karaman, R. (2020). Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25: 5789, https:\/\/doi.org\/10.3390\/molecules25245789.","DOI":"10.3390\/molecules25245789"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_028","doi-asserted-by":"crossref","unstructured":"Brown, G.C. (2019). The endotoxin hypothesis of neurodegeneration. J.\u00a0Neuroinflammation 16: 180, https:\/\/doi.org\/10.1186\/s12974-019-1564-7.","DOI":"10.1186\/s12974-019-1564-7"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_029","doi-asserted-by":"crossref","unstructured":"Bu, X.L., Yao, X.Q., Jiao, S.S., Zeng, F., Liu, Y.H., Xiang, Y., Liang, C.R., Wang, Q.H., Wang, X., Cao, H.Y., et al.. (2015). A study on the association between infectious burden and Alzheimer\u2019s disease. Eur. J.\u00a0Neurol. 22: 1519\u20131525, https:\/\/doi.org\/10.1111\/ene.12477.","DOI":"10.1111\/ene.12477"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_030","doi-asserted-by":"crossref","unstructured":"Cairns, D.M., Rouleau, N., Parker, R.N., Walsh, K.G., Gehrke, L., and Kaplan, D.L. (2020). A 3D human brain-like tissue model of herpes-induced Alzheimer\u2019s disease. Sci. Adv. 6: eaay8828, https:\/\/doi.org\/10.1126\/sciadv.aay8828.","DOI":"10.1126\/sciadv.aay8828"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_031","doi-asserted-by":"crossref","unstructured":"Cao, W. and Zheng, H. (2018). Peripheral immune system in aging and Alzheimer\u2019s disease. Mol. Neurodegener. 13: 51, https:\/\/doi.org\/10.1186\/s13024-018-0284-2.","DOI":"10.1186\/s13024-018-0284-2"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_032","doi-asserted-by":"crossref","unstructured":"Carbone, I., Lazzarotto, T., Ianni, M., Porcellini, E., Forti, P., Masliah, E., Gabrielli, L., and Licastro, F. (2014). Herpes virus in Alzheimer\u2019s disease: relation to progression of the disease. Neurobiol. Aging 35: 122\u2013129, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.06.024.","DOI":"10.1016\/j.neurobiolaging.2013.06.024"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_033","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas, V.M., Boller, F., and Rom\u00e1n, G.C. (2019). Helicobacter pylori, vascular risk factors and cognition in U.S. older adults. Brain Sci. 9: 370 https:\/\/doi.org\/10.3390\/brainsci9120370.","DOI":"10.3390\/brainsci9120370"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_034","doi-asserted-by":"crossref","unstructured":"Carter, C.J. (2017). Genetic, transcriptome, proteomic, and epidemiological evidence for blood-brain barrier disruption and polymicrobial brain invasion as determinant factors in Alzheimer\u2019s disease. J.\u00a0Alzheimer\u2019s Dis. Rep. 1: 125\u2013157, https:\/\/doi.org\/10.3233\/adr-170017.","DOI":"10.3233\/ADR-170017"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_035","doi-asserted-by":"crossref","unstructured":"Casta\u00f1o Barrios, L., Da Silva Pinheiro, A.P., Gibaldi, D., Silva, A.A., Machado Rodrigues, E.S.P., Roff\u00ea, E., da Costa Santiago, H., Tostes Gazzinelli, R., Mineo, J.R., Silva, N.M., et al.. (2021). Behavioral alterations in long-term Toxoplasma gondii infection of C57BL\/6 mice are associated with neuroinflammation and disruption of the blood brain barrier. PLoS One 16: e0258199, https:\/\/doi.org\/10.1371\/journal.pone.0258199.","DOI":"10.1371\/journal.pone.0258199"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_036","doi-asserted-by":"crossref","unstructured":"Cerovic, M., Forloni, G., and Balducci, C. (2019). Neuroinflammation and the gut microbiota: possible alternative therapeutic targets to counteract Alzheimer\u2019s disease? Front. Aging Neurosci. 11: 284, https:\/\/doi.org\/10.3389\/fnagi.2019.00284.","DOI":"10.3389\/fnagi.2019.00284"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_037","doi-asserted-by":"crossref","unstructured":"Chang, Y.P., Chiu, G.F., Kuo, F.C., Lai, C.L., Yang, Y.H., Hu, H.M., Chang, P.Y., Chen, C.Y., Wu, D.C., and Yu, F.J. (2013). Eradication of Helicobacter pylori is associated with the progression of dementia: a population-based study. Gastroenterol. Res. Pract. 2013: 175729, https:\/\/doi.org\/10.1155\/2013\/175729.","DOI":"10.1155\/2013\/175729"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_038","doi-asserted-by":"crossref","unstructured":"Chesnokova, V., Pechnick, R.N., and Wawrowsky, K. (2016). Chronic peripheral inflammation, hippocampal neurogenesis, and behavior. Brain Behav. Immun. 58: 1\u20138, https:\/\/doi.org\/10.1016\/j.bbi.2016.01.017.","DOI":"10.1016\/j.bbi.2016.01.017"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_039","doi-asserted-by":"crossref","unstructured":"Chi, L., Cheng, X., Lin, L., Yang, T., Sun, J., Feng, Y., Liang, F., Pei, Z., and Teng, W. (2021). Porphyromonas gingivalis-induced cognitive impairment is associated with gut dysbiosis, neuroinflammation, and glymphatic dysfunction. Front. Cell. Infect. Microbiol. 11: 755925, https:\/\/doi.org\/10.3389\/fcimb.2021.755925.","DOI":"10.3389\/fcimb.2021.755925"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_040","doi-asserted-by":"crossref","unstructured":"Chou, R.C., Kane, M., Ghimire, S., Gautam, S., and Gui, J. (2016). Treatment for rheumatoid arthritis and risk of Alzheimer\u2019s disease: a nested case-control analysis. CNS Drugs 30: 1111\u20131120, https:\/\/doi.org\/10.1007\/s40263-016-0374-z.","DOI":"10.1007\/s40263-016-0374-z"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_041","doi-asserted-by":"crossref","unstructured":"Ciaccio, M., Lo Sasso, B., Scazzone, C., Gambino, C.M., Ciaccio, A.M., Bivona, G., Piccoli, T., Giglio, R.V., and Agnello, L. (2021). COVID-19 and Alzheimer\u2019s disease. Brain Sci. 11: 370, https:\/\/doi.org\/10.3390\/brainsci11030305.","DOI":"10.3390\/brainsci11030305"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_042","doi-asserted-by":"crossref","unstructured":"Cirrito, J.R., Deane, R., Fagan, A.M., Spinner, M.L., Parsadanian, M., Finn, M.B., Jiang, H., Prior, J.L., Sagare, A., Bales, K.R., et al.. (2005). P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J.\u00a0Clin. Invest. 115: 3285\u20133290, https:\/\/doi.org\/10.1172\/jci25247.","DOI":"10.1172\/JCI25247"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_043","doi-asserted-by":"crossref","unstructured":"Cloarec, R., Bauer, S., Luche, H., Buhler, E., Pallesi-Pocachard, E., Salmi, M., Courtens, S., Massacrier, A., Grenot, P., Teissier, N., et al.. (2016). Cytomegalovirus infection of the rat developing brain in utero prominently targets immune cells and promotes early microglial activation. PLoS One 11: e0160176, https:\/\/doi.org\/10.1371\/journal.pone.0160176.","DOI":"10.1371\/journal.pone.0160176"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_044","doi-asserted-by":"crossref","unstructured":"Coras, R., Siebzehnrubl, F.A., Pauli, E., Huttner, H.B., Njunting, M., Kobow, K., Villmann, C., Hahnen, E., Neuhuber, W., Weigel, D., et al.. (2010). Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans. Brain 133: 3359\u20133372, https:\/\/doi.org\/10.1093\/brain\/awq215.","DOI":"10.1093\/brain\/awq215"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_045","doi-asserted-by":"crossref","unstructured":"Cribbs, D.H., Azizeh, B.Y., Cotman, C.W., and LaFerla, F.M. (2000). Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer\u2019s A beta peptide. Biochemistry 39: 5988\u20135994, https:\/\/doi.org\/10.1021\/bi000029f.","DOI":"10.1021\/bi000029f"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_046","doi-asserted-by":"crossref","unstructured":"Daniels, M.J., Rivers-Auty, J., Schilling, T., Spencer, N.G., Watremez, W., Fasolino, V., Booth, S.J., White, C.S., Baldwin, A.G., Freeman, S., et al.. (2016). Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models. Nat. Commun. 7: 12504, https:\/\/doi.org\/10.1038\/ncomms12504.","DOI":"10.1038\/ncomms12504"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_047","doi-asserted-by":"crossref","unstructured":"De Chiara, G., Marcocci, M.E., Civitelli, L., Argnani, R., Piacentini, R., Ripoli, C., Manservigi, R., Grassi, C., Garaci, E., and Palamara, A.T. (2010). APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5: e13989, https:\/\/doi.org\/10.1371\/journal.pone.0013989.","DOI":"10.1371\/journal.pone.0013989"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_048","doi-asserted-by":"crossref","unstructured":"De Chiara, G., Piacentini, R., Fabiani, M., Mastrodonato, A., Marcocci, M.E., Limongi, D., Napoletani, G., Protto, V., Coluccio, P., Celestino, I., et al.. (2019). Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 15: e1007617, https:\/\/doi.org\/10.1371\/journal.ppat.1007617.","DOI":"10.1371\/journal.ppat.1007617"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_049","doi-asserted-by":"crossref","unstructured":"Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H.W., et al.. (2004). LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43: 333\u2013344, https:\/\/doi.org\/10.1016\/j.neuron.2004.07.017.","DOI":"10.1016\/j.neuron.2004.07.017"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_050","doi-asserted-by":"crossref","unstructured":"Deardorff, W.J. and Grossberg, G.T. (2017). Targeting neuroinflammation in Alzheimer\u2019s disease: evidence for NSAIDs and novel therapeutics. Expert Rev. Neurother. 17: 17\u201332, https:\/\/doi.org\/10.1080\/14737175.2016.1200972.","DOI":"10.1080\/14737175.2016.1200972"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_051","doi-asserted-by":"crossref","unstructured":"Demars, M., Hu, Y.S., Gadadhar, A., and Lazarov, O. (2010). Impaired neurogenesis is an early event in the etiology of familial Alzheimer\u2019s disease in transgenic mice. J.\u00a0Neurosci. Res. 88: 2103\u20132117, https:\/\/doi.org\/10.1002\/jnr.22387.","DOI":"10.1002\/jnr.22387"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_052","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Z\u00fa\u00f1iga, J., More, J., Melgar-Rodr\u00edguez, S., Jim\u00e9nez-Uni\u00f3n, M., Villalobos-Orchard, F., Mu\u00f1oz-Manr\u00edquez, C., Monasterio, G., Vald\u00e9s, J.L., Vernal, R., and Paula-Lima, A. (2020). Alzheimer\u2019s disease-like pathology triggered by Porphyromonas gingivalis in wild type rats is serotype dependent. Front. Immunol. 11: 588036, https:\/\/doi.org\/10.3389\/fimmu.2020.588036.","DOI":"10.3389\/fimmu.2020.588036"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_053","doi-asserted-by":"crossref","unstructured":"Dill, J., Patel, A.R., Yang, X.L., Bachoo, R., Powell, C.M., and Li, S. (2010). A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons. J.\u00a0Neurosci. 30: 963\u2013972, https:\/\/doi.org\/10.1523\/jneurosci.5045-09.2010.","DOI":"10.1523\/JNEUROSCI.5045-09.2010"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_054","doi-asserted-by":"crossref","unstructured":"Ding, Y., Ren, J., Yu, H., Yu, W., and Zhou, Y. (2018). Porphyromonas gingivalis, a periodontitis causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice. Immun. Ageing 15: 6, https:\/\/doi.org\/10.1186\/s12979-017-0110-7.","DOI":"10.1186\/s12979-017-0110-7"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_055","doi-asserted-by":"crossref","unstructured":"Dioguardi, M., Crincoli, V., Laino, L., Alovisi, M., Sovereto, D., Mastrangelo, F., Russo, L.L., and Muzio, L.L. (2020). The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer\u2019s disease: a systematic review. J.\u00a0Clin. Med. 9: 495, https:\/\/doi.org\/10.3390\/jcm9020495.","DOI":"10.3390\/jcm9020495"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_056","doi-asserted-by":"crossref","unstructured":"Dobri, A.M., Dud\u0103u, M., Enciu, A.M., and Hinescu, M.E. (2021). CD36 in Alzheimer\u2019s disease: an overview of molecular mechanisms and therapeutic targeting. Neuroscience 453: 301\u2013311, https:\/\/doi.org\/10.1016\/j.neuroscience.2020.11.003.","DOI":"10.1016\/j.neuroscience.2020.11.003"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_057","doi-asserted-by":"crossref","unstructured":"Dominy, S.S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al.. (2019). Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv. 5: eaau3333, https:\/\/doi.org\/10.1126\/sciadv.aau3333.","DOI":"10.1126\/sciadv.aau3333"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_058","doi-asserted-by":"crossref","unstructured":"Doost Mohammadpour, J., Hosseinmardi, N., Janahmadi, M., Fathollahi, Y., Motamedi, F., and Rohampour, K. (2015). Non-selective NSAIDs improve the amyloid-\u03b2-mediated suppression of memory and synaptic plasticity. Pharmacol. Biochem. Behav. 132: 33\u201341, https:\/\/doi.org\/10.1016\/j.pbb.2015.02.012.","DOI":"10.1016\/j.pbb.2015.02.012"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_059","doi-asserted-by":"crossref","unstructured":"Doulberis, M., Kotronis, G., Gialamprinou, D., Polyzos, S.A., Papaefthymiou, A., Katsinelos, P., and Kountouras, J. (2021). Alzheimer\u2019s disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement. Int. J.\u00a0Neurosci. 131: 289\u2013301, https:\/\/doi.org\/10.1080\/00207454.2020.1738432.","DOI":"10.1080\/00207454.2020.1738432"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_060","doi-asserted-by":"crossref","unstructured":"Eimer, W.A., Vijaya Kumar, D.K., Navalpur Shanmugam, N.K., Rodriguez, A.S., Mitchell, T., Washicosky, K.J., Gy\u00f6rgy, B., Breakefield, X.O., Tanzi, R.E., and Moir, R.D. (2018). Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99: 56\u201363.e53, https:\/\/doi.org\/10.1016\/j.neuron.2018.11.043.","DOI":"10.1016\/j.neuron.2018.06.030"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_061","doi-asserted-by":"crossref","unstructured":"Elwishahy, A., Antia, K., Bhusari, S., Ilechukwu, N.C., Horstick, O., and Winkler, V. (2021). Porphyromonas gingivalis as a risk factor to Alzheimer\u2019s disease: a systematic review. J.\u00a0Alzheimer\u2019s Dis. Rep. 5: 721\u2013732, https:\/\/doi.org\/10.3233\/adr-200237.","DOI":"10.3233\/ADR-200237"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_062","doi-asserted-by":"crossref","unstructured":"Emery, D.C., Shoemark, D.K., Batstone, T.E., Waterfall, C.M., Coghill, J.A., Cerajewska, T.L., Davies, M., West, N.X., and Allen, S.J. (2017). 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer\u2019s post-mortem brain. Front. Aging Neurosci. 9: 195, https:\/\/doi.org\/10.3389\/fnagi.2017.00195.","DOI":"10.3389\/fnagi.2017.00195"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_063","doi-asserted-by":"crossref","unstructured":"Erickson, M.A. and Banks, W.A. (2013). Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J.\u00a0Cereb. Blood Flow Metab. 33: 1500\u20131513, https:\/\/doi.org\/10.1038\/jcbfm.2013.135.","DOI":"10.1038\/jcbfm.2013.135"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_064","doi-asserted-by":"crossref","unstructured":"F\u00e9art, C., Helmer, C., Fleury, H., B\u00e9jot, Y., Ritchie, K., Amouyel, P., Schraen-Maschke, S., Bu\u00e9e, L., Lambert, J.C., Letenneur, L., et al.. (2011). Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS One 6: e29480, https:\/\/doi.org\/10.1371\/journal.pone.0029480.","DOI":"10.1371\/journal.pone.0029480"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_065","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Casta\u00f1eda, A., Lu, P., Geraghty, A.C., Song, E., Lee, M.H., Wood, J., O\u2019Dea, M.R., Dutton, S., Shamardani, K., Nwangwu, K., et al.. (2022). Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185: 2452\u20132468.e2416, https:\/\/doi.org\/10.1016\/j.cell.2022.06.008.","DOI":"10.1016\/j.cell.2022.06.008"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_066","doi-asserted-by":"crossref","unstructured":"Fr\u00f6lich, L. (2020). Alzheimer\u2019s disease\u00a0\u2013 the \u2018microbial hypothesis\u2019 from a clinical and neuroimaging perspective. Psychiatry Res. Neuroimaging 306: 111181, https:\/\/doi.org\/10.1016\/j.pscychresns.2020.111181.","DOI":"10.1016\/j.pscychresns.2020.111181"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_067","doi-asserted-by":"crossref","unstructured":"Fulop, T., Witkowski, J.M., Larbi, A., Khalil, A., Herbein, G., and Frost, E.H. (2019). Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer\u2019s disease? J.\u00a0Neurovirol. 25: 634\u2013647, https:\/\/doi.org\/10.1007\/s13365-019-00732-3.","DOI":"10.1007\/s13365-019-00732-3"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_068","doi-asserted-by":"crossref","unstructured":"Gale, S.D., Erickson, L.D., Brown, B.L., and Hedges, D.W. (2015). Interaction between Helicobacter pylori and latent toxoplasmosis and demographic variables on cognitive function in young to middle-aged adults. PLoS One 10: e0116874, https:\/\/doi.org\/10.1371\/journal.pone.0116874.","DOI":"10.1371\/journal.pone.0116874"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_069","doi-asserted-by":"crossref","unstructured":"Gasmi, A., Tippairote, T., Mujawdiya, P.K., Gasmi Benahmed, A., Menzel, A., Dadar, M., and Bj\u00f8rklund, G. (2021). Neurological involvements of SARS-CoV2 infection. Mol. Neurobiol. 58: 944\u2013949, https:\/\/doi.org\/10.1007\/s12035-020-02070-6.","DOI":"10.1007\/s12035-020-02070-6"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_070","doi-asserted-by":"crossref","unstructured":"Giridharan, V.V., Masud, F., Petronilho, F., Dal-Pizzol, F., and Barichello, T. (2019). Infection-induced systemic inflammation is a potential driver of Alzheimer\u2019s disease progression. Front. Aging Neurosci. 11: 122, https:\/\/doi.org\/10.3389\/fnagi.2019.00122.","DOI":"10.3389\/fnagi.2019.00122"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_071","unstructured":"Giunta, B., Zhou, Y., Hou, H., Rrapo, E., Fernandez, F., and Tan, J. (2008). HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide. Int. J.\u00a0Clin. Exp. Pathol. 1: 260\u2013275."},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_072","unstructured":"Giunta, B., Hou, H., Zhu, Y., Rrapo, E., Tian, J., Takashi, M., Commins, D., Singer, E., He, J., Fernandez, F., et al.. (2009). HIV-1 Tat contributes to Alzheimer\u2019s disease-like pathology in PSAPP mice. Int. J.\u00a0Clin. Exp. Pathol. 2: 433\u2013443."},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_073","doi-asserted-by":"crossref","unstructured":"Goyal, D., Ali, S.A., and Singh, R.K. (2021). Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer\u2019s disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 106: 110112, https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110112.","DOI":"10.1016\/j.pnpbp.2020.110112"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_074","doi-asserted-by":"crossref","unstructured":"Green, D.A., Masliah, E., Vinters, H.V., Beizai, P., Moore, D.J., and Achim, C.L. (2005). Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. Aids 19: 407\u2013411, https:\/\/doi.org\/10.1097\/01.aids.0000161770.06158.5c.","DOI":"10.1097\/01.aids.0000161770.06158.5c"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_075","doi-asserted-by":"crossref","unstructured":"Griffin, W.S., Sheng, J.G., Royston, M.C., Gentleman, S.M., McKenzie, J.E., Graham, D.I., Roberts, G.W., and Mrak, R.E. (1998). Glial-neuronal interactions in Alzheimer\u2019s disease: the potential role of a \u2018cytokine cycle\u2019 in disease progression. Brain Pathol. 8: 65\u201372, https:\/\/doi.org\/10.1111\/j.1750-3639.1998.tb00136.x.","DOI":"10.1111\/j.1750-3639.1998.tb00136.x"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_076","doi-asserted-by":"crossref","unstructured":"Haditsch, U., Roth, T., Rodriguez, L., Hancock, S., Cecere, T., Nguyen, M., Arastu-Kapur, S., Broce, S., Raha, D., Lynch, C.C., et al.. (2020). Alzheimer\u2019s disease-like neurodegeneration in Porphyromonas gingivalis infected neurons with persistent expression of active gingipains. J.\u00a0Alzheimer\u2019s Dis. 75: 1361\u20131376, https:\/\/doi.org\/10.3233\/jad-200393.","DOI":"10.3233\/JAD-200393"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_077","doi-asserted-by":"crossref","unstructured":"Hall, B., Mak, E., Cervenka, S., Aigbirhio, F.I., Rowe, J.B., and O\u2019Brien, J.T. (2017). In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Ageing Res. Rev. 36: 50\u201363, https:\/\/doi.org\/10.1016\/j.arr.2017.03.002.","DOI":"10.1016\/j.arr.2017.03.002"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_078","doi-asserted-by":"crossref","unstructured":"Han, M.L., Chen, J.H., Tsai, M.K., Liou, J.M., Chiou, J.M., Chiu, M.J., and Chen, Y.C. (2018). Association between Helicobacter pylori infection and cognitive impairment in the elderly. J.\u00a0Formosan Med. Assoc. 117: 994\u20131002, https:\/\/doi.org\/10.1016\/j.jfma.2017.11.005.","DOI":"10.1016\/j.jfma.2017.11.005"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_079","doi-asserted-by":"crossref","unstructured":"Hansen, D.V., Hanson, J.E., and Sheng, M. (2018). Microglia in Alzheimer\u2019s disease. J.\u00a0Cell Biol. 217: 459\u2013472, https:\/\/doi.org\/10.1083\/jcb.201709069.","DOI":"10.1083\/jcb.201709069"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_080","doi-asserted-by":"crossref","unstructured":"Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K.D., Frisoni, G., Neher, J.J., F\u00e5k, F., Jucker, M., Lasser, T., et al.. (2017). Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 7: 41802, https:\/\/doi.org\/10.1038\/srep41802.","DOI":"10.1038\/srep41802"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_081","doi-asserted-by":"crossref","unstructured":"Hardy, J.A. and Higgins, G.A. (1992). Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256: 184\u2013185, https:\/\/doi.org\/10.1126\/science.1566067.","DOI":"10.1126\/science.1566067"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_082","doi-asserted-by":"crossref","unstructured":"Harris, S.A. and Harris, E.A. (2015). Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer\u2019s disease. J.\u00a0Alzheimer\u2019s Dis. 48: 319\u2013353, https:\/\/doi.org\/10.3233\/jad-142853.","DOI":"10.3233\/JAD-142853"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_083","doi-asserted-by":"crossref","unstructured":"Hashioka, S., Wu, Z., and Klegeris, A. (2021). Glia-driven neuroinflammation and systemic inflammation in Alzheimer\u2019s disease. Curr. Neuropharmacol. 19: 908\u2013924, https:\/\/doi.org\/10.2174\/1570159x18666201111104509.","DOI":"10.2174\/1570159X18666201111104509"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_084","doi-asserted-by":"crossref","unstructured":"Hayden, K.M., Zandi, P.P., Khachaturian, A.S., Szekely, C.A., Fotuhi, M., Norton, M.C., Tschanz, J.T., Pieper, C.F., Corcoran, C., Lyketsos, C.G., et al.. (2007). Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology 69: 275\u2013282, https:\/\/doi.org\/10.1212\/01.wnl.0000265223.25679.2a.","DOI":"10.1212\/01.wnl.0000265223.25679.2a"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_085","doi-asserted-by":"crossref","unstructured":"He, Q., Liu, H., Huang, C., Wang, R., Luo, M., and Lu, W. (2020). Herpes simplex virus 1-induced blood-brain barrier damage involves apoptosis associated with GM130-mediated golgi stress. Front. Mol. Neurosci. 13: 2, https:\/\/doi.org\/10.3389\/fnmol.2020.00002.","DOI":"10.3389\/fnmol.2020.00002"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_086","doi-asserted-by":"crossref","unstructured":"He, X.F., Li, L.L., Xian, W.B., Li, M.Y., Zhang, L.Y., Xu, J.H., Pei, Z., Zheng, H.Q., and Hu, X.Q. (2021). Chronic colitis exacerbates NLRP3-dependent neuroinflammation and cognitive impairment in middle-aged brain. J.\u00a0Neuroinflammation 18: 153, https:\/\/doi.org\/10.1186\/s12974-021-02199-8.","DOI":"10.1186\/s12974-021-02199-8"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_087","doi-asserted-by":"crossref","unstructured":"Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al.. (2020). Neurologic features in severe SARS-CoV-2 infection. N. Engl. J.\u00a0Med. 382: 2268\u20132270, https:\/\/doi.org\/10.1056\/nejmc2008597.","DOI":"10.1056\/NEJMc2008597"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_088","doi-asserted-by":"crossref","unstructured":"Hickman, S.E., Allison, E.K., and El Khoury, J. (2008). Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J.\u00a0Neurosci. 28: 8354\u20138360, https:\/\/doi.org\/10.1523\/jneurosci.0616-08.2008.","DOI":"10.1523\/JNEUROSCI.0616-08.2008"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_089","doi-asserted-by":"crossref","unstructured":"Hollands, C., Tobin, M.K., Hsu, M., Musaraca, K., Yu, T.S., Mishra, R., Kernie, S.G., and Lazarov, O. (2017). Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer\u2019s disease by compromising hippocampal inhibition. Mol. Neurodegener. 12: 64, https:\/\/doi.org\/10.1186\/s13024-017-0207-7.","DOI":"10.1186\/s13024-017-0207-7"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_090","doi-asserted-by":"crossref","unstructured":"Holmes, C. (2013). Review: systemic inflammation and Alzheimer\u2019s disease. Neuropathol. Appl. Neurobiol. 39: 51\u201368, https:\/\/doi.org\/10.1111\/j.1365-2990.2012.01307.x.","DOI":"10.1111\/j.1365-2990.2012.01307.x"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_091","doi-asserted-by":"crossref","unstructured":"Honjo, K., van Reekum, R., and Verhoeff, N.P. (2009). Alzheimer\u2019s disease and infection: do infectious agents contribute to progression of Alzheimer\u2019s disease? Alzheimer\u2019s Dementia 5: 348\u2013360, https:\/\/doi.org\/10.1016\/j.jalz.2008.12.001.","DOI":"10.1016\/j.jalz.2008.12.001"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_092","doi-asserted-by":"crossref","unstructured":"Hu, S., Rotschafer, J.H., Lokensgard, J.R., and Cheeran, M.C. (2014). Activated CD8+ T lymphocytes inhibit neural stem\/progenitor cell proliferation: role of interferon-gamma. PLoS One 9: e105219, https:\/\/doi.org\/10.1371\/journal.pone.0105219.","DOI":"10.1371\/journal.pone.0105219"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_093","doi-asserted-by":"crossref","unstructured":"Huang, S.Y., Yang, Y.X., Kuo, K., Li, H.Q., Shen, X.N., Chen, S.D., Cui, M., Tan, L., Dong, Q., and Yu, J.T. (2021a). Herpesvirus infections and Alzheimer\u2019s disease: a Mendelian randomization study. Alzheimer\u2019s Res. Ther. 13: 158, https:\/\/doi.org\/10.1186\/s13195-021-00905-5.","DOI":"10.1186\/s13195-021-00905-5"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_094","doi-asserted-by":"crossref","unstructured":"Huang, X., Hussain, B., and Chang, J. (2021b). Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci. Ther. 27: 36\u201347, https:\/\/doi.org\/10.1111\/cns.13569.","DOI":"10.1111\/cns.13569"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_095","doi-asserted-by":"crossref","unstructured":"Hui, Z., Zhijun, Y., Yushan, Y., Liping, C., Yiying, Z., Difan, Z., Chunglit, C.T., and Wei, C. (2020). The combination of acyclovir and dexamethasone protects against Alzheimer\u2019s disease-related cognitive impairments in mice. Psychopharmacology 237: 1851\u20131860, https:\/\/doi.org\/10.1007\/s00213-020-05503-1.","DOI":"10.1007\/s00213-020-05503-1"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_096","doi-asserted-by":"crossref","unstructured":"Ide, M., Harris, M., Stevens, A., Sussams, R., Hopkins, V., Culliford, D., Fuller, J., Ibbett, P., Raybould, R., Thomas, R., et al.. (2016). Periodontitis and cognitive decline in Alzheimer\u2019s disease. PLoS One 11: e0151081, https:\/\/doi.org\/10.1371\/journal.pone.0151081.","DOI":"10.1371\/journal.pone.0151081"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_097","doi-asserted-by":"crossref","unstructured":"Itzhaki, R.F. (2021). Overwhelming evidence for a major role for herpes simplex virus type 1 (HSV1) in Alzheimer\u2019s disease (AD); underwhelming evidence against. Vaccines 9: 679, https:\/\/doi.org\/10.3390\/vaccines9060679.","DOI":"10.3390\/vaccines9060679"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_098","doi-asserted-by":"crossref","unstructured":"Jackson, D.E., Ward, C.M., Wang, R., and Newman, P.J. (1997). The protein-tyrosine phosphatase SHP-2 binds platelet\/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling. J.\u00a0Biol. Chem. 272: 6986\u20136993, https:\/\/doi.org\/10.1074\/jbc.272.11.6986.","DOI":"10.1074\/jbc.272.11.6986"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_099","doi-asserted-by":"crossref","unstructured":"Jung, B.K., Pyo, K.H., Shin, K.Y., Hwang, Y.S., Lim, H., Lee, S.J., Moon, J.H., Lee, S.H., Suh, Y.H., Chai, J.Y., et al.. (2012). Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer\u2019s disease. PLoS One 7: e33312, https:\/\/doi.org\/10.1371\/journal.pone.0033312.","DOI":"10.1371\/journal.pone.0033312"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_100","doi-asserted-by":"crossref","unstructured":"Kanagasingam, S., Chukkapalli, S.S., Welbury, R., and Singhrao, S.K. (2020). Porphyromonas gingivalis is a strong risk factor for Alzheimer\u2019s disease. J.\u00a0Alzheimer\u2019s Dis. Rep. 4: 501\u2013511, https:\/\/doi.org\/10.3233\/adr-200250.","DOI":"10.3233\/ADR-200250"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_101","doi-asserted-by":"crossref","unstructured":"Khan, S., Barve, K.H., and Kumar, M.S. (2020). Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease. Curr. Neuropharmacol. 18: 1106\u20131125, https:\/\/doi.org\/10.2174\/1570159x18666200528142429.","DOI":"10.2174\/1570159X18666200528142429"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_102","doi-asserted-by":"crossref","unstructured":"Khokale, R., Kang, A., Buchanan-Peart, K.R., Nelson, M.L., Awolumate, O.J., and Cancarevic, I. (2020). Alzheimer\u2019s gone viral: could herpes simplex virus type-1 be stealing your memories? Cureus 12: e11726, https:\/\/doi.org\/10.7759\/cureus.11726.","DOI":"10.7759\/cureus.11726"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_103","doi-asserted-by":"crossref","unstructured":"Komaroff, A.L. (2020). Can infections cause alzheimer disease? Jama 324: 239\u2013240, https:\/\/doi.org\/10.1001\/jama.2020.4085.","DOI":"10.1001\/jama.2020.4085"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_104","doi-asserted-by":"crossref","unstructured":"Kountouras, J., Tsolaki, M., Gavalas, E., Boziki, M., Zavos, C., Karatzoglou, P., Chatzopoulos, D., and Venizelos, I. (2006). Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66: 938\u2013940, https:\/\/doi.org\/10.1212\/01.wnl.0000203644.68059.5f.","DOI":"10.1212\/01.wnl.0000203644.68059.5f"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_105","doi-asserted-by":"crossref","unstructured":"Kountouras, J., Gavalas, E., Zavos, C., Stergiopoulos, C., Chatzopoulos, D., Kapetanakis, N., and Gisakis, D. (2007). Alzheimer\u2019s disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Med. Hypotheses 68: 378\u2013388, https:\/\/doi.org\/10.1016\/j.mehy.2006.06.052.","DOI":"10.1016\/j.mehy.2006.06.052"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_106","doi-asserted-by":"crossref","unstructured":"Kountouras, J., Boziki, M., Gavalas, E., Zavos, C., Deretzi, G., Grigoriadis, N., Tsolaki, M., Chatzopoulos, D., Katsinelos, P., Tzilves, D., et al.. (2009a). Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer\u2019s disease. Int. J.\u00a0Neurosci. 119: 765\u2013777, https:\/\/doi.org\/10.1080\/00207450902782083.","DOI":"10.1080\/00207450902782083"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_107","doi-asserted-by":"crossref","unstructured":"Kountouras, J., Boziki, M., Gavalas, E., Zavos, C., Grigoriadis, N., Deretzi, G., Tzilves, D., Katsinelos, P., Tsolaki, M., Chatzopoulos, D., et al.. (2009b). Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer\u2019s disease. J.\u00a0Neurol. 256: 758\u2013767, https:\/\/doi.org\/10.1007\/s00415-009-5011-z.","DOI":"10.1007\/s00415-009-5011-z"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_108","doi-asserted-by":"crossref","unstructured":"Kountouras, J., Boziki, M., Gavalas, E., Zavos, C., Deretzi, G., Chatzigeorgiou, S., Katsinelos, P., Grigoriadis, N., Giartza-Taxidou, E., and Venizelos, I. (2010). Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cognit. Behav. Neurol. 23: 199\u2013204, https:\/\/doi.org\/10.1097\/wnn.0b013e3181df3034.","DOI":"10.1097\/WNN.0b013e3181df3034"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_109","doi-asserted-by":"crossref","unstructured":"KrumanII, Nath, A., and Mattson, M.P. (1998). HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 154: 276\u2013288, https:\/\/doi.org\/10.1006\/exnr.1998.6958.","DOI":"10.1006\/exnr.1998.6958"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_110","doi-asserted-by":"crossref","unstructured":"Kumar, D.K., Choi, S.H., Washicosky, K.J., Eimer, W.A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L.E., Tanzi, R.E., et al.. (2016). Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Sci. Transl. Med. 8: 340ra372, https:\/\/doi.org\/10.1126\/scitranslmed.aaf1059.","DOI":"10.1126\/scitranslmed.aaf1059"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_111","doi-asserted-by":"crossref","unstructured":"Lau, S.F., Fu, A.K.Y., and Ip, N.Y. (2021). Cytokine signaling convergence regulates the microglial state transition in Alzheimer\u2019s disease. Cell. Mol. Life Sci. 78: 4703\u20134712, https:\/\/doi.org\/10.1007\/s00018-021-03810-0.","DOI":"10.1007\/s00018-021-03810-0"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_112","doi-asserted-by":"crossref","unstructured":"Laval, K. and Enquist, L.W. (2021). The potential role of herpes simplex virus type 1 and neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. Front. Neurol. 12: 658695, https:\/\/doi.org\/10.3389\/fneur.2021.658695.","DOI":"10.3389\/fneur.2021.658695"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_113","doi-asserted-by":"crossref","unstructured":"Le Page, A., Dupuis, G., Frost, E.H., Larbi, A., Pawelec, G., Witkowski, J.M., and Fulop, T. (2018). Role of the peripheral innate immune system in the development of Alzheimer\u2019s disease. Exp. Gerontol. 107: 59\u201366, https:\/\/doi.org\/10.1016\/j.exger.2017.12.019.","DOI":"10.1016\/j.exger.2017.12.019"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_114","doi-asserted-by":"crossref","unstructured":"Lee, K.H., Kwon, D.E., Do Han, K., La, Y., and Han, S.H. (2020). Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: a population-based cohort study. BMC Neurol. 20: 216, https:\/\/doi.org\/10.1186\/s12883-020-01776-3.","DOI":"10.1186\/s12883-020-01776-3"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_115","doi-asserted-by":"crossref","unstructured":"Lehrer, S. (2014). Nasal NSAIDs for Alzheimer\u2019s disease. Am. J.\u00a0Alzheimer\u2019s Dis. Other Dementias 29: 401\u2013403, https:\/\/doi.org\/10.1177\/1533317513518658.","DOI":"10.1177\/1533317513518658"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_116","doi-asserted-by":"crossref","unstructured":"Leibrand, C.R., Paris, J.J., Ghandour, M.S., Knapp, P.E., Kim, W.K., Hauser, K.F., and McRae, M. (2017). HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice. Neurosci. Lett. 640: 136\u2013143, https:\/\/doi.org\/10.1016\/j.neulet.2016.12.073.","DOI":"10.1016\/j.neulet.2016.12.073"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_117","doi-asserted-by":"crossref","unstructured":"Leira, Y., Iglesias-Rey, R., G\u00f3mez-Lado, N., Aguiar, P., Campos, F., D\u2019Aiuto, F., Castillo, J., Blanco, J., and Sobrino, T. (2019). Porphyromonas gingivalis lipopolysaccharide-induced periodontitis and serum amyloid-beta peptides. Arch. Oral Biol. 99: 120\u2013125, https:\/\/doi.org\/10.1016\/j.archoralbio.2019.01.008.","DOI":"10.1016\/j.archoralbio.2019.01.008"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_118","doi-asserted-by":"crossref","unstructured":"Letenneur, L., P\u00e9r\u00e8s, K., Fleury, H., Garrigue, I., Barberger-Gateau, P., Helmer, C., Orgogozo, J.M., Gauthier, S., and Dartigues, J.F. (2008). Seropositivity to herpes simplex virus antibodies and risk of Alzheimer\u2019s disease: a population-based cohort study. PLoS One 3: e3637, https:\/\/doi.org\/10.1371\/journal.pone.0003637.","DOI":"10.1371\/journal.pone.0003637"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_119","doi-asserted-by":"crossref","unstructured":"Li Puma, D.D., Piacentini, R., Leone, L., Gironi, K., Marcocci, M.E., De Chiara, G., Palamara, A.T., and Grassi, C. (2019). Herpes simplex virus type-1 infection impairs adult hippocampal neurogenesis via amyloid-\u03b2 protein accumulation. Stem Cells 37: 1467\u20131480, https:\/\/doi.org\/10.1002\/stem.3072.","DOI":"10.1002\/stem.3072"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_120","doi-asserted-by":"crossref","unstructured":"Lim, S.L., Rodriguez-Ortiz, C.J., and Kitazawa, M. (2015). Infection, systemic inflammation, and Alzheimer\u2019s disease. Microbes Infect. 17: 549\u2013556, https:\/\/doi.org\/10.1016\/j.micinf.2015.04.004.","DOI":"10.1016\/j.micinf.2015.04.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_121","doi-asserted-by":"crossref","unstructured":"Lin, W.R., Jennings, R., Smith, T.L., Wozniak, M.A., and Itzhaki, R.F. (2001). Vaccination prevents latent HSV1 infection of mouse brain. Neurobiol. Aging 22: 699\u2013703, https:\/\/doi.org\/10.1016\/s0197-4580(01)00239-1.","DOI":"10.1016\/S0197-4580(01)00239-1"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_122","doi-asserted-by":"crossref","unstructured":"Liu, H., Qiu, K., He, Q., Lei, Q., and Lu, W. (2019). Mechanisms of blood-brain barrier disruption in herpes simplex encephalitis. J.\u00a0Neuroimmune Pharmacol. 14: 157\u2013172, https:\/\/doi.org\/10.1007\/s11481-018-9821-6.","DOI":"10.1007\/s11481-018-9821-6"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_123","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, S., Li, X., Liu, E., Wang, X., Zhou, Q., Ye, J., and Wang, J.Z. (2020). Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier. Biosci. Rep. 40: BSR20193629, https:\/\/doi.org\/10.1042\/bsr20193629.","DOI":"10.1042\/BSR20193629"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_124","doi-asserted-by":"crossref","unstructured":"Liu, N.Y., Sun, J.H., Jiang, X.F., and Li, H. (2021). Helicobacter pylori infection and risk for developing dementia: an evidence-based meta-analysis of case-control and cohort studies. Aging 13: 22571\u201322587, https:\/\/doi.org\/10.18632\/aging.203571.","DOI":"10.18632\/aging.203571"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_125","doi-asserted-by":"crossref","unstructured":"Loeb, M.B., Molloy, D.W., Smieja, M., Standish, T., Goldsmith, C.H., Mahony, J., Smith, S., Borrie, M., Decoteau, E., Davidson, W., et al.. (2004). A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease. J.\u00a0Am. Geriatr. Soc. 52: 381\u2013387, https:\/\/doi.org\/10.1111\/j.1532-5415.2004.52109.x.","DOI":"10.1111\/j.1532-5415.2004.52109.x"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_126","doi-asserted-by":"crossref","unstructured":"Lopatko Lindman, K., Hemmingsson, E.S., Weidung, B., Br\u00e4nnstr\u00f6m, J., Josefsson, M., Olsson, J., Elgh, F., Nordstr\u00f6m, P., and L\u00f6vheim, H. (2021a). Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden. Alzheimer\u2019s Dementia 7: e12119, https:\/\/doi.org\/10.1002\/trc2.12119.","DOI":"10.1002\/trc2.12119"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_127","doi-asserted-by":"crossref","unstructured":"Lopatko Lindman, K., Weidung, B., Olsson, J., Josefsson, M., Johansson, A., Eriksson, S., Hallmans, G., Elgh, F., and L\u00f6vheim, H. (2021b). Plasma amyloid-\u03b2 in relation to antibodies against herpes simplex virus, cytomegalovirus, and chlamydophila pneumoniae. J.\u00a0Alzheimer\u2019s Dis. Rep. 5: 229\u2013235, https:\/\/doi.org\/10.3233\/adr-210008.","DOI":"10.3233\/ADR-210008"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_128","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Pic\u00f3n, F.R., Snellman, A., Eskola, O., Helin, S., Solin, O., Haaparanta-Solin, M., and Rinne, J.O. (2018). Neuroinflammation appears early on PET imaging and then plateaus in a mouse model of alzheimer disease. J.\u00a0Nucl. Med. 59: 509\u2013515, https:\/\/doi.org\/10.2967\/jnumed.117.197608.","DOI":"10.2967\/jnumed.117.197608"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_129","doi-asserted-by":"crossref","unstructured":"Luo, M.H., Hannemann, H., Kulkarni, A.S., Schwartz, P.H., O\u2019Dowd, J.M., and Fortunato, E.A. (2010). Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J.\u00a0Virol. 84: 3528\u20133541, https:\/\/doi.org\/10.1128\/jvi.02161-09.","DOI":"10.1128\/JVI.02161-09"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_130","doi-asserted-by":"crossref","unstructured":"Lyman, M., Lloyd, D.G., Ji, X., Vizcaychipi, M.P., and Ma, D. (2014). Neuroinflammation: the role and consequences. Neurosci. Res. 79: 1\u201312, https:\/\/doi.org\/10.1016\/j.neures.2013.10.004.","DOI":"10.1016\/j.neures.2013.10.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_131","doi-asserted-by":"crossref","unstructured":"Ma, M. and Nath, A. (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J.\u00a0Virol. 71: 2495\u20132499, https:\/\/doi.org\/10.1128\/jvi.71.3.2495-2499.1997.","DOI":"10.1128\/jvi.71.3.2495-2499.1997"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_132","doi-asserted-by":"crossref","unstructured":"Mackenzie, I.R. and Munoz, D.G. (1998). Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50: 986\u2013990, https:\/\/doi.org\/10.1212\/wnl.50.4.986.","DOI":"10.1212\/WNL.50.4.986"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_133","doi-asserted-by":"crossref","unstructured":"Mahmoudvand, H., Sheibani, V., Shojaee, S., Mirbadie, S.R., Keshavarz, H., Esmaeelpour, K., Keyhani, A.R., and Ziaali, N. (2016). Toxoplasma gondii infection potentiates cognitive impairments of Alzheimer\u2019s disease in the BALB\/c mice. J.\u00a0Parasitol. 102: 629\u2013635, https:\/\/doi.org\/10.1645\/16-28.","DOI":"10.1645\/16-28"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_134","doi-asserted-by":"crossref","unstructured":"Malaguarnera, M., Bella, R., Alagona, G., Ferri, R., Carnemolla, A., and Pennisi, G. (2004). Helicobacter pylori and Alzheimer\u2019s disease: a possible link. Eur. J.\u00a0Intern. Med. 15: 381\u2013386, https:\/\/doi.org\/10.1016\/j.ejim.2004.05.008.","DOI":"10.1016\/j.ejim.2004.05.008"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_135","doi-asserted-by":"crossref","unstructured":"Martens, Y.A., Zhao, N., Liu, C.C., Kanekiyo, T., Yang, A.J., Goate, A.M., Holtzman, D.M., and Bu, G. (2022). ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110: 1304\u20131317, https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004.","DOI":"10.1016\/j.neuron.2022.03.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_136","doi-asserted-by":"crossref","unstructured":"McGeer, P.L. and McGeer, E.G. (2013). The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 126: 479\u2013497, https:\/\/doi.org\/10.1007\/s00401-013-1177-7.","DOI":"10.1007\/s00401-013-1177-7"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_137","doi-asserted-by":"crossref","unstructured":"McRae, M. (2016). HIV and viral protein effects on the blood brain barrier. Tissue Barriers 4: e1143543, https:\/\/doi.org\/10.1080\/21688370.2016.1143543.","DOI":"10.1080\/21688370.2016.1143543"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_138","doi-asserted-by":"crossref","unstructured":"Mei, F., Xie, M., Huang, X., Long, Y., Lu, X., Wang, X., and Chen, L. (2020). Porphyromonas gingivalis and its systemic impact: current status. Pathogens 9: 944, https:\/\/doi.org\/10.3390\/pathogens9110944.","DOI":"10.3390\/pathogens9110944"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_139","doi-asserted-by":"crossref","unstructured":"Meneses, G., C\u00e1rdenas, G., Espinosa, A., Rassy, D., P\u00e9rez-Osorio, I.N., B\u00e1rcena, B., Fleury, A., Besedovsky, H., Fragoso, G., and Sciutto, E. (2019). Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury. Ann. N. Y. Acad. Sci. 1437: 43\u201356, https:\/\/doi.org\/10.1111\/nyas.13985.","DOI":"10.1111\/nyas.13985"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_140","doi-asserted-by":"crossref","unstructured":"Miller, A.L., Bessho, S., Grando, K., and T\u00fckel, \u00c7. (2021). Microbiome or infections: amyloid-containing biofilms as a trigger for complex human diseases. Front. Immunol. 12: 638867, https:\/\/doi.org\/10.3389\/fimmu.2021.638867.","DOI":"10.3389\/fimmu.2021.638867"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_141","doi-asserted-by":"crossref","unstructured":"Millett, C.E., Burdick, K.E., and Kubicki, M.R. (2022). The effects of peripheral inflammation on the brain-A neuroimaging perspective. Harv. Rev. Psychiatry 30: 54\u201358, https:\/\/doi.org\/10.1097\/hrp.0000000000000323.","DOI":"10.1097\/HRP.0000000000000323"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_142","doi-asserted-by":"crossref","unstructured":"Minter, M.R., Hinterleitner, R., Meisel, M., Zhang, C., Leone, V., Zhang, X., Oyler-Castrillo, P., Zhang, X., Musch, M.W., Shen, X., et al.. (2017). Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP(SWE)\/PS1(\u0394E9) murine model of Alzheimer\u2019s disease. Sci. Rep. 7: 10411, https:\/\/doi.org\/10.1038\/s41598-017-11047-w.","DOI":"10.1038\/s41598-017-11047-w"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_143","doi-asserted-by":"crossref","unstructured":"M\u00f6hle, L., Israel, N., Paarmann, K., Krohn, M., Pietkiewicz, S., M\u00fcller, A., Lavrik, I.N., Buguliskis, J.S., Schott, B.H., Schl\u00fcter, D., et al.. (2016). Chronic Toxoplasma gondii infection enhances \u03b2-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol. Commun. 4: 25, https:\/\/doi.org\/10.1186\/s40478-016-0293-8.","DOI":"10.1186\/s40478-016-0293-8"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_144","doi-asserted-by":"crossref","unstructured":"Moir, R.D., Lathe, R., and Tanzi, R.E. (2018). The antimicrobial protection hypothesis of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 14: 1602\u20131614, https:\/\/doi.org\/10.1016\/j.jalz.2018.06.3040.","DOI":"10.1016\/j.jalz.2018.06.3040"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_145","doi-asserted-by":"crossref","unstructured":"Monje, M.L., Toda, H., and Palmer, T.D. (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science 302: 1760\u20131765, https:\/\/doi.org\/10.1126\/science.1088417.","DOI":"10.1126\/science.1088417"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_146","doi-asserted-by":"crossref","unstructured":"Montagne, A., Barnes, S.R., Sweeney, M.D., Halliday, M.R., Sagare, A.P., Zhao, Z., Toga, A.W., Jacobs, R.E., Liu, C.Y., Amezcua, L., et al.. (2015). Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85: 296\u2013302, https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032.","DOI":"10.1016\/j.neuron.2014.12.032"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_147","doi-asserted-by":"crossref","unstructured":"Moreno-Jim\u00e9nez, E.P., Flor-Garc\u00eda, M., Terreros-Roncal, J., R\u00e1bano, A., Cafini, F., Pallas-Bazarra, N., \u00c1vila, J., and Llorens-Mart\u00edn, M. (2019). Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer\u2019s disease. Nat. Med. 25: 554\u2013560, https:\/\/doi.org\/10.1038\/s41591-019-0375-9.","DOI":"10.1038\/s41591-019-0375-9"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_148","doi-asserted-by":"crossref","unstructured":"Moutachakkir, M., Lamrani Hanchi, A., Baraou, A., Boukhira, A., and Chellak, S. (2017). Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein. Ann. Biol. Clin. 75: 225\u2013229, https:\/\/doi.org\/10.1684\/abc.2017.1232.","DOI":"10.1684\/abc.2017.1232"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_149","doi-asserted-by":"crossref","unstructured":"Mu, Y. and Gage, F.H. (2011). Adult hippocampal neurogenesis and its role in Alzheimer\u2019s disease. Mol. Neurodegener. 6: 85, https:\/\/doi.org\/10.1186\/1750-1326-6-85.","DOI":"10.1186\/1750-1326-6-85"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_150","doi-asserted-by":"crossref","unstructured":"Murphy, M.J., Fani, L., Ikram, M.K., Ghanbari, M., and Ikram, M.A. (2021). Herpes simplex virus 1 and the risk of dementia: a population-based study. Sci. Rep. 11: 8691, https:\/\/doi.org\/10.1038\/s41598-021-87963-9.","DOI":"10.1038\/s41598-021-87963-9"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_151","doi-asserted-by":"crossref","unstructured":"Murta, V. and Ferrari, C.C. (2013). Influence of peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models. Mol. Cell. Neurosci. 53: 6\u201313, https:\/\/doi.org\/10.1016\/j.mcn.2012.06.004.","DOI":"10.1016\/j.mcn.2012.06.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_152","doi-asserted-by":"crossref","unstructured":"Murta, V. and Ferrari, C. (2016). Peripheral inflammation and demyelinating diseases. Adv. Exp. Med. Biol. 949: 263\u2013285, https:\/\/doi.org\/10.1007\/978-3-319-40764-7_13.","DOI":"10.1007\/978-3-319-40764-7_13"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_153","doi-asserted-by":"crossref","unstructured":"Nalivaeva, N.N., Belyaev, N.D., Kerridge, C., and Turner, A.J. (2014). Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer\u2019s disease. Front. Aging Neurosci. 6: 235, https:\/\/doi.org\/10.3389\/fnagi.2014.00235.","DOI":"10.3389\/fnagi.2014.00235"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_154","doi-asserted-by":"crossref","unstructured":"Nayeri Chegeni, T., Sarvi, S., Moosazadeh, M., Sharif, M., Aghayan, S.A., Amouei, A., Hosseininejad, Z., and Daryani, A. (2019). Is Toxoplasma gondii a potential risk factor for Alzheimer\u2019s disease? A systematic review and meta-analysis. Microb. Pathog. 137: 103751, https:\/\/doi.org\/10.1016\/j.micpath.2019.103751.","DOI":"10.1016\/j.micpath.2019.103751"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_155","doi-asserted-by":"crossref","unstructured":"Netland, E.E., Newton, J.L., Majocha, R.E., and Tate, B.A. (1998). Indomethacin reverses the microglial response to amyloid beta-protein. Neurobiol. Aging 19: 201\u2013204, https:\/\/doi.org\/10.1016\/s0197-4580(98)00047-5.","DOI":"10.1016\/S0197-4580(98)00047-5"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_156","doi-asserted-by":"crossref","unstructured":"Nie, R., Wu, Z., Ni, J., Zeng, F., Yu, W., Zhang, Y., Kadowaki, T., Kashiwazaki, H., Teeling, J.L., and Zhou, Y. (2019). Porphyromonas gingivalis infection induces amyloid-\u03b2 accumulation in monocytes\/macrophages. J.\u00a0Alzheimer\u2019s Dis. 72: 479\u2013494, https:\/\/doi.org\/10.3233\/jad-190298.","DOI":"10.3233\/JAD-190298"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_157","doi-asserted-by":"crossref","unstructured":"Nonaka, S., Kadowaki, T., and Nakanishi, H. (2022). Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins. Neurochem. Int. 154: 105282, https:\/\/doi.org\/10.1016\/j.neuint.2022.105282.","DOI":"10.1016\/j.neuint.2022.105282"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_158","doi-asserted-by":"crossref","unstructured":"Nwafor, D.C., Brichacek, A.L., Mohammad, A.S., Griffith, J., Lucke-Wold, B.P., Benkovic, S.A., Geldenhuys, W.J., Lockman, P.R., and Brown, C.M. (2019). Targeting the blood-brain barrier to prevent sepsis-associated cognitive impairment. J.\u00a0Cent. Nerv. Syst. Dis. 11: 1179573519840652, https:\/\/doi.org\/10.1177\/1179573519840652.","DOI":"10.1177\/1179573519840652"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_159","doi-asserted-by":"crossref","unstructured":"Odeberg, J., Wolmer, N., Falci, S., Westgren, M., Seiger, A., and S\u00f6derberg-Naucl\u00e9r, C. (2006). Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J.\u00a0Virol. 80: 8929\u20138939, https:\/\/doi.org\/10.1128\/jvi.00676-06.","DOI":"10.1128\/JVI.00676-06"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_160","doi-asserted-by":"crossref","unstructured":"Olsen, I. (2021). Possible effects of Porphyromonas gingivalis on the blood-brain barrier in Alzheimer\u2019s disease. Expert Rev. Anti-Infect. Ther. 19: 1367\u20131371, https:\/\/doi.org\/10.1080\/14787210.2021.1925540.","DOI":"10.1080\/14787210.2021.1925540"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_161","doi-asserted-by":"crossref","unstructured":"Olsthoorn, L., Vreeken, D., and Kiliaan, A.J. (2021). Gut microbiome, inflammation, and cerebrovascular function: link between obesity and cognition. Front. Neurosci. 15: 761456, https:\/\/doi.org\/10.3389\/fnins.2021.761456.","DOI":"10.3389\/fnins.2021.761456"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_162","doi-asserted-by":"crossref","unstructured":"Ortega, M. and Ances, B.M. (2014). Role of HIV in amyloid metabolism. J.\u00a0Neuroimmune Pharmacol. 9: 483\u2013491, https:\/\/doi.org\/10.1007\/s11481-014-9546-0.","DOI":"10.1007\/s11481-014-9546-0"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_163","doi-asserted-by":"crossref","unstructured":"Paouri, E. and Georgopoulos, S. (2019). Systemic and CNS inflammation crosstalk: implications for Alzheimer\u2019s disease. Curr. Alzheimer Res. 16: 559\u2013574, https:\/\/doi.org\/10.2174\/1567205016666190321154618.","DOI":"10.2174\/1567205016666190321154618"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_164","doi-asserted-by":"crossref","unstructured":"Park, J.C., Han, S.H., and Mook-Jung, I. (2020). Peripheral inflammatory biomarkers in Alzheimer\u2019s disease: a brief review. BMB Rep. 53: 10\u201319, https:\/\/doi.org\/10.5483\/bmbrep.2020.53.1.309.","DOI":"10.5483\/BMBRep.2020.53.1.309"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_165","doi-asserted-by":"crossref","unstructured":"Perry, V.H. (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun. 18: 407\u2013413, https:\/\/doi.org\/10.1016\/j.bbi.2004.01.004.","DOI":"10.1016\/j.bbi.2004.01.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_166","doi-asserted-by":"crossref","unstructured":"Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C., Morris, J.C., Rabins, P.V., Ritchie, K., Rossor, M., Thal, L., and Winblad, B. (2001). Current concepts in mild cognitive impairment. Arch. Neurol. 58: 1985\u20131992, https:\/\/doi.org\/10.1001\/archneur.58.12.1985.","DOI":"10.1001\/archneur.58.12.1985"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_167","doi-asserted-by":"crossref","unstructured":"Pflugrad, H., Meyer, G.J., Dirks, M., Raab, P., Tryc, A.B., Goldbecker, A., Worthmann, H., Wilke, F., Boellaard, R., Yaqub, M., et al.. (2016). Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunction. J.\u00a0Viral. Hepat. 23: 348\u2013357, https:\/\/doi.org\/10.1111\/jvh.12496.","DOI":"10.1111\/jvh.12496"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_168","doi-asserted-by":"crossref","unstructured":"Pisa, D., Alonso, R., R\u00e1bano, A., Horst, M.N., and Carrasco, L. (2016). Fungal enolase, \u03b2-tubulin, and chitin are detected in brain tissue from Alzheimer\u2019s disease patients. Front. Microbiol. 7: 1772, https:\/\/doi.org\/10.3389\/fmicb.2016.01772.","DOI":"10.3389\/fmicb.2016.01772"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_169","doi-asserted-by":"crossref","unstructured":"Poole, S., Singhrao, S.K., Kesavalu, L., Curtis, M.A., and Crean, S. (2013). Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer\u2019s disease brain tissue. J.\u00a0Alzheimer\u2019s Dis. 36: 665\u2013677, https:\/\/doi.org\/10.3233\/jad-121918.","DOI":"10.3233\/JAD-121918"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_170","doi-asserted-by":"crossref","unstructured":"Powell-Doherty, R.D., Abbott, A.R.N., Nelson, L.A., and Bertke, A.S. (2020). Amyloid-\u03b2 and p-tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons. J.\u00a0Virol. 94: e01874\u2013e018719, https:\/\/doi.org\/10.1128\/jvi.01874-19.","DOI":"10.1128\/JVI.01874-19"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_171","doi-asserted-by":"crossref","unstructured":"Pritchard, A.B., Fabian, Z., Lawrence, C.L., Morton, G., Crean, S., and Alder, J.E. (2022). An investigation into the effects of outer membrane vesicles and lipopolysaccharide of Porphyromonas gingivalis on blood-brain barrier integrity, permeability, and disruption of scaffolding proteins in a human in\u00a0vitro model. J.\u00a0Alzheimer\u2019s Dis. 86: 343\u2013364, https:\/\/doi.org\/10.3233\/jad-215054.","DOI":"10.3233\/JAD-215054"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_172","doi-asserted-by":"crossref","unstructured":"Pugazhenthi, S., Qin, L., and Reddy, P.H. (2017). Common neurodegenerative pathways in obesity, diabetes, and Alzheimer\u2019s disease. Biochim. Biophys. Acta Mol. Basis Dis. 1863: 1037\u20131045, https:\/\/doi.org\/10.1016\/j.bbadis.2016.04.017.","DOI":"10.1016\/j.bbadis.2016.04.017"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_173","doi-asserted-by":"crossref","unstructured":"Pulliam, L. (2009). HIV regulation of amyloid beta production. J.\u00a0Neuroimmune Pharmacol. 4: 213\u2013217, https:\/\/doi.org\/10.1007\/s11481-009-9151-9.","DOI":"10.1007\/s11481-009-9151-9"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_174","doi-asserted-by":"crossref","unstructured":"Qiao, H., Guo, M., Shang, J., Zhao, W., Wang, Z., Liu, N., Li, B., Zhou, Y., Wu, Y., and Chen, P. (2020). Herpes simplex virus type 1 infection leads to neurodevelopmental disorder-associated neuropathological changes. PLoS Pathog. 16: e1008899, https:\/\/doi.org\/10.1371\/journal.ppat.1008899.","DOI":"10.1371\/journal.ppat.1008899"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_175","doi-asserted-by":"crossref","unstructured":"Qosa, H., Abuznait, A.H., Hill, R.A., and Kaddoumi, A. (2012). Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer\u2019s disease. J.\u00a0Alzheimer\u2019s Dis. 31: 151\u2013165, https:\/\/doi.org\/10.3233\/jad-2012-120319.","DOI":"10.3233\/JAD-2012-120319"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_176","doi-asserted-by":"crossref","unstructured":"Reines, S.A., Block, G.A., Morris, J.C., Liu, G., Nessly, M.L., Lines, C.R., Norman, B.A., and Baranak, C.C. (2004). Rofecoxib: no effect on Alzheimer\u2019s disease in a 1-year, randomized, blinded, controlled study. Neurology 62: 66\u201371, https:\/\/doi.org\/10.1212\/wnl.62.1.66.","DOI":"10.1212\/WNL.62.1.66"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_177","doi-asserted-by":"crossref","unstructured":"Remick, D.G. (2014). Systemic inflammation. In: McManus, L.M. and Mitchell, R.N. (Eds.). Pathobiology of human disease. Academic Press, San Diego, pp. 315\u2013322.","DOI":"10.1016\/B978-0-12-386456-7.01809-8"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_178","doi-asserted-by":"crossref","unstructured":"Rempel, H.C. and Pulliam, L. (2005). HIV-1 Tat inhibits neprilysin and elevates amyloid beta. Aids 19: 127\u2013135, https:\/\/doi.org\/10.1097\/00002030-200501280-00004.","DOI":"10.1097\/00002030-200501280-00004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_179","doi-asserted-by":"crossref","unstructured":"Riazi, K., Galic, M.A., and Pittman, Q.J. (2010). Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 89: 34\u201342, https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.09.004.","DOI":"10.1016\/j.eplepsyres.2009.09.004"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_180","doi-asserted-by":"crossref","unstructured":"Ritchie, K., Chan, D., and Watermeyer, T. (2020). The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun. 2: fcaa069, https:\/\/doi.org\/10.1093\/braincomms\/fcaa069.","DOI":"10.1093\/braincomms\/fcaa069"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_181","doi-asserted-by":"crossref","unstructured":"Rodriguez, J.D., Royall, D., Daum, L.T., Kagan-Hallet, K., and Chambers, J.P. (2005). Amplification of herpes simplex type 1 and human herpes type 5 viral DNA from formalin-fixed Alzheimer brain tissue. Neurosci. Lett. 390: 37\u201341, https:\/\/doi.org\/10.1016\/j.neulet.2005.07.052.","DOI":"10.1016\/j.neulet.2005.07.052"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_182","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez, J.J., Jones, V.C., Tabuchi, M., Allan, S.M., Knight, E.M., LaFerla, F.M., Oddo, S., and Verkhratsky, A. (2008). Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer\u2019s disease. PLoS One 3: e2935, https:\/\/doi.org\/10.1371\/journal.pone.0002935.","DOI":"10.1371\/journal.pone.0002935"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_183","doi-asserted-by":"crossref","unstructured":"Rotschafer, J.H., Hu, S., Little, M., Erickson, M., Low, W.C., and Cheeran, M.C. (2013). Modulation of neural stem\/progenitor cell proliferation during experimental Herpes Simplex encephalitis is mediated by differential FGF-2 expression in the adult brain. Neurobiol. Dis. 58: 144\u2013155, https:\/\/doi.org\/10.1016\/j.nbd.2013.05.018.","DOI":"10.1016\/j.nbd.2013.05.018"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_184","doi-asserted-by":"crossref","unstructured":"Roubaud-Baudron, C., Krolak-Salmon, P., Quadrio, I., M\u00e9graud, F., and Salles, N. (2012). Impact of chronic Helicobacter pylori infection on Alzheimer\u2019s disease: preliminary results. Neurobiol. Aging 33: 1009.e11-1009.e19.","DOI":"10.1016\/j.neurobiolaging.2011.10.021"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_185","doi-asserted-by":"crossref","unstructured":"Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Ch\u00e9telat, G., Teunissen, C.E., Cummings, J., and van der Flier, W.M. (2021). Alzheimer\u2019s disease. Lancet 397: 1577\u20131590, https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4.","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_186","doi-asserted-by":"crossref","unstructured":"Shawahna, R. (2015). Physical and metabolic integrity of the blood-brain barrier in HIV infection: a special focus on intercellular junctions, influx and efflux transporters and metabolizing enzymes. Curr. Drug Metab. 16: 105\u2013123, https:\/\/doi.org\/10.2174\/138920021602150713114715.","DOI":"10.2174\/138920021602150713114715"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_187","doi-asserted-by":"crossref","unstructured":"Sheets, S.M., Potempa, J., Travis, J., Casiano, C.A., and Fletcher, H.M. (2005). Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect. Immun. 73: 1543\u20131552, https:\/\/doi.org\/10.1128\/iai.73.3.1543-1552.2005.","DOI":"10.1128\/IAI.73.3.1543-1552.2005"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_188","doi-asserted-by":"crossref","unstructured":"Shi, Y., Manis, M., Long, J., Wang, K., Sullivan, P.M., Remolina Serrano, J., Hoyle, R., and Holtzman, D.M. (2019). Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J.\u00a0Exp. Med. 216: 2546\u20132561, https:\/\/doi.org\/10.1084\/jem.20190980.","DOI":"10.1084\/jem.20190980"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_189","doi-asserted-by":"crossref","unstructured":"Shim, S.M., Cheon, H.S., Jo, C., Koh, Y.H., Song, J., and Jeon, J.P. (2017). Elevated epstein-barr virus antibody level is associated with cognitive decline in the Korean elderly. J.\u00a0Alzheimer\u2019s Dis. 55: 293\u2013301, https:\/\/doi.org\/10.3233\/jad-160563.","DOI":"10.3233\/JAD-160563"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_190","doi-asserted-by":"crossref","unstructured":"Si, Z.Z., Zou, C.J., Mei, X., Li, X.F., Luo, H., Shen, Y., Hu, J., Li, X.X., Wu, L., and Liu, Y. (2023). Targeting neuroinflammation in Alzheimer\u2019s disease: from mechanisms to clinical applications. Neural. Regen. Res. 18: 708\u2013715, https:\/\/doi.org\/10.4103\/1673-5374.353484.","DOI":"10.4103\/1673-5374.353484"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_191","doi-asserted-by":"crossref","unstructured":"Singh, V.K., Kumar, S., and Tapryal, S. (2020). Aggregation propensities of herpes simplex virus-1 proteins and derived peptides: an in\u00a0silico and in\u00a0vitro analysis. ACS Omega 5: 12964\u201312973, https:\/\/doi.org\/10.1021\/acsomega.0c00730.","DOI":"10.1021\/acsomega.0c00730"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_192","doi-asserted-by":"crossref","unstructured":"Singhrao, S.K., Harding, A., Poole, S., Kesavalu, L., and Crean, S. (2015). Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer\u2019s disease. Mediators Inflammation 2015: 137357, https:\/\/doi.org\/10.1155\/2015\/137357.","DOI":"10.1155\/2015\/137357"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_193","doi-asserted-by":"crossref","unstructured":"Sochocka, M., Zwoli\u0144ska, K., and Leszek, J. (2017). The infectious etiology of Alzheimer\u2019s disease. Curr. Neuropharmacol. 15: 996\u20131009, https:\/\/doi.org\/10.2174\/1570159x15666170313122937.","DOI":"10.2174\/1570159X15666170313122937"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_194","doi-asserted-by":"crossref","unstructured":"Sochocka, M., Donskow-\u0141ysoniewska, K., Diniz, B.S., Kurpas, D., Brzozowska, E., and Leszek, J. (2019). The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer\u2019s disease-a critical review. Mol. Neurobiol. 56: 1841\u20131851, https:\/\/doi.org\/10.1007\/s12035-018-1188-4.","DOI":"10.1007\/s12035-018-1188-4"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_195","doi-asserted-by":"crossref","unstructured":"Soininen, H., West, C., Robbins, J., and Niculescu, L. (2007). Long-term efficacy and safety of celecoxib in Alzheimer\u2019s disease. Dementia Geriatr. Cognit. Disord. 23: 8\u201321, https:\/\/doi.org\/10.1159\/000096588.","DOI":"10.1159\/000096588"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_196","doi-asserted-by":"crossref","unstructured":"Soung, A.L., Vanderheiden, A., Nordvig, A.S., Sissoko, C.A., Canoll, P., Mariani, M.B., Jiang, X., Bricker, T., Rosoklija, G.B., Arango, V., et al.. (2022). COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain 145: 4193\u20134201, https:\/\/doi.org\/10.1093\/brain\/awac270.","DOI":"10.1093\/brain\/awac270"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_197","doi-asserted-by":"crossref","unstructured":"Sparks Stein, P., Steffen, M.J., Smith, C., Jicha, G., Ebersole, J.L., Abner, E., and Dawson, D.3rd. (2012). Serum antibodies to periodontal pathogens are a risk factor for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 8: 196\u2013203, https:\/\/doi.org\/10.1016\/j.jalz.2011.04.006.","DOI":"10.1016\/j.jalz.2011.04.006"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_198","doi-asserted-by":"crossref","unstructured":"Stanley, L.C., Mrak, R.E., Woody, R.C., Perrot, L.J., Zhang, S., Marshak, D.R., Nelson, S.J., and Griffin, W.S. (1994). Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer\u2019s disease. J.\u00a0Neuropathol. Exp. Neurol. 53: 231\u2013238, https:\/\/doi.org\/10.1097\/00005072-199405000-00003.","DOI":"10.1097\/00005072-199405000-00003"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_199","doi-asserted-by":"crossref","unstructured":"Stein, S.R., Ramelli, S.C., Grazioli, A., Chung, J.Y., Singh, M., Yinda, C.K., Winkler, C.W., Sun, J., Dickey, J.M., Ylaya, K., et al.. (2022). SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612: 758\u2013763, https:\/\/doi.org\/10.1038\/s41586-022-05542-y.","DOI":"10.1038\/s41586-022-05542-y"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_200","doi-asserted-by":"crossref","unstructured":"Steiner, I. (2011). Herpes simplex virus encephalitis: new infection or reactivation? Curr. Opin. Neurol. 24: 268\u2013274, https:\/\/doi.org\/10.1097\/wco.0b013e328346be6f.","DOI":"10.1097\/WCO.0b013e328346be6f"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_201","doi-asserted-by":"crossref","unstructured":"Sumi, N., Nishioku, T., Takata, F., Matsumoto, J., Watanabe, T., Shuto, H., Yamauchi, A., Dohgu, S., and Kataoka, Y. (2010). Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cell Mol. Neurobiol. 30: 247\u2013253, https:\/\/doi.org\/10.1007\/s10571-009-9446-7.","DOI":"10.1007\/s10571-009-9446-7"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_202","doi-asserted-by":"crossref","unstructured":"Sun, Y., Koyama, Y., and Shimada, S. (2022). Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation? Front. Aging Neurosci. 14: 903455, https:\/\/doi.org\/10.3389\/fnagi.2022.903455.","DOI":"10.3389\/fnagi.2022.903455"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_203","doi-asserted-by":"crossref","unstructured":"S\u00fc\u03b2, P., Lana, A.J., and Schlachetzki, J.C.M. (2021). Chronic peripheral inflammation: a possible contributor to neurodegenerative diseases. Neural. Regen. Res. 16: 1711\u20131714, https:\/\/doi.org\/10.4103\/1673-5374.306060.","DOI":"10.4103\/1673-5374.306060"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_204","doi-asserted-by":"crossref","unstructured":"Swardfager, W., Lanct\u00f4t, K., Rothenburg, L., Wong, A., Cappell, J., and Herrmann, N. (2010). A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol. Psychiatry 68: 930\u2013941, https:\/\/doi.org\/10.1016\/j.biopsych.2010.06.012.","DOI":"10.1016\/j.biopsych.2010.06.012"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_205","doi-asserted-by":"crossref","unstructured":"Takeda, S., Sato, N., Uchio-Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., and Morishita, R. (2010). Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. U. S. A. 107: 7036\u20137041, https:\/\/doi.org\/10.1073\/pnas.1000645107.","DOI":"10.1073\/pnas.1000645107"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_206","doi-asserted-by":"crossref","unstructured":"Tan, Z.S., Beiser, A.S., Vasan, R.S., Roubenoff, R., Dinarello, C.A., Harris, T.B., Benjamin, E.J., Au, R., Kiel, D.P., Wolf, P.A., et al.. (2007). Inflammatory markers and the risk of Alzheimer disease: the Framingham study. Neurology 68: 1902\u20131908, https:\/\/doi.org\/10.1212\/01.wnl.0000263217.36439.da.","DOI":"10.1212\/01.wnl.0000263217.36439.da"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_207","doi-asserted-by":"crossref","unstructured":"Terreros-Roncal, J., Moreno-Jim\u00e9nez, E.P., Flor-Garc\u00eda, M., Rodr\u00edguez-Moreno, C.B., Trinchero, M.F., Cafini, F., R\u00e1bano, A., and Llorens-Mart\u00edn, M. (2021). Impact of neurodegenerative diseases on human adult hippocampal neurogenesis. Science 374: 1106\u20131113, https:\/\/doi.org\/10.1126\/science.abl5163.","DOI":"10.1126\/science.abl5163"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_208","doi-asserted-by":"crossref","unstructured":"Tobin, M.K., Musaraca, K., Disouky, A., Shetti, A., Bheri, A., Honer, W.G., Kim, N., Dawe, R.J., Bennett, D.A., Arfanakis, K., et al.. (2019). Human hippocampal neurogenesis persists in aged adults and Alzheimer\u2019s disease patients. Cell Stem Cell 24: 974\u2013982.e973, https:\/\/doi.org\/10.1016\/j.stem.2019.05.003.","DOI":"10.1016\/j.stem.2019.05.003"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_209","doi-asserted-by":"crossref","unstructured":"Toda, T., Parylak, S.L., Linker, S.B., and Gage, F.H. (2019). The role of adult hippocampal neurogenesis in brain health and disease. Mol. Psychiatry 24: 67\u201387, https:\/\/doi.org\/10.1038\/s41380-018-0036-2.","DOI":"10.1038\/s41380-018-0036-2"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_210","doi-asserted-by":"crossref","unstructured":"Tomiyama, T., Asano, S., Suwa, Y., Morita, T., Kataoka, K., Mori, H., and Endo, N. (1994). Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in\u00a0vitro. Biochem. Biophys. Res. Commun. 204: 76\u201383, https:\/\/doi.org\/10.1006\/bbrc.1994.2428.","DOI":"10.1006\/bbrc.1994.2428"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_211","doi-asserted-by":"crossref","unstructured":"Tournier, B.B., Tsartsalis, S., Rigaud, D., Fossey, C., Cailly, T., Fabis, F., Pham, T., Gr\u00e9goire, M.C., K\u00f6vari, E., Moulin-Sallanon, M., et al.. (2019). TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 121: 95\u2013105, https:\/\/doi.org\/10.1016\/j.nbd.2018.09.022.","DOI":"10.1016\/j.nbd.2018.09.022"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_212","doi-asserted-by":"crossref","unstructured":"Tr\u00e4ger, U. and Tabrizi, S.J. (2013). Peripheral inflammation in neurodegeneration. J.\u00a0Mol. Med. 91: 673\u2013681, https:\/\/doi.org\/10.1007\/s00109-013-1026-0.","DOI":"10.1007\/s00109-013-1026-0"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_213","doi-asserted-by":"crossref","unstructured":"Tuomisto, A.E., M\u00e4kinen, M.J., and V\u00e4yrynen, J.P. (2019). Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J.\u00a0Gastroenterol. 25: 4383\u20134404, https:\/\/doi.org\/10.3748\/wjg.v25.i31.4383.","DOI":"10.3748\/wjg.v25.i31.4383"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_214","doi-asserted-by":"crossref","unstructured":"Tzeng, N.S., Chung, C.H., Lin, F.H., Chiang, C.P., Yeh, C.B., Huang, S.Y., Lu, R.B., Chang, H.A., Kao, Y.C., Yeh, H.W., et al.. (2018). Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections-a nationwide, population-based cohort study in Taiwan. Neurotherapeutics 15: 417\u2013429, https:\/\/doi.org\/10.1007\/s13311-018-0611-x.","DOI":"10.1007\/s13311-018-0611-x"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_215","doi-asserted-by":"crossref","unstructured":"Umeda, T., Tanaka, A., Sakai, A., Yamamoto, A., Sakane, T., and Tomiyama, T. (2018). Intranasal rifampicin for Alzheimer\u2019s disease prevention. Alzheimer\u2019s Dementia 4: 304\u2013313, https:\/\/doi.org\/10.1016\/j.trci.2018.06.012.","DOI":"10.1016\/j.trci.2018.06.012"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_216","doi-asserted-by":"crossref","unstructured":"Varatharaj, A., Thomas, N., Ellul, M.A., Davies, N.W.S., Pollak, T.A., Tenorio, E.L., Sultan, M., Easton, A., Breen, G., Zandi, M., et al.. (2020). Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7: 875\u2013882, https:\/\/doi.org\/10.1016\/s2215-0366(20)30287-x.","DOI":"10.2139\/ssrn.3601761"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_217","doi-asserted-by":"crossref","unstructured":"Vermunt, L., Sikkes, S.A.M., van den Hout, A., Handels, R., Bos, I., van der Flier, W.M., Kern, S., Ousset, P.J., Maruff, P., Skoog, I., et al.. (2019). Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype. Alzheimer\u2019s Dementia 15: 888\u2013898, https:\/\/doi.org\/10.1016\/j.jalz.2019.04.001.","DOI":"10.1016\/j.jalz.2019.04.001"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_218","doi-asserted-by":"crossref","unstructured":"Verret, L., Jankowsky, J.L., Xu, G.M., Borchelt, D.R., and Rampon, C. (2007). Alzheimer\u2019s-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J.\u00a0Neurosci. 27: 6771\u20136780, https:\/\/doi.org\/10.1523\/jneurosci.5564-06.2007.","DOI":"10.1523\/JNEUROSCI.5564-06.2007"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_219","doi-asserted-by":"crossref","unstructured":"Vlad, S.C., Miller, D.R., Kowall, N.W., and Felson, D.T. (2008). Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70: 1672\u20131677, https:\/\/doi.org\/10.1212\/01.wnl.0000311269.57716.63.","DOI":"10.1212\/01.wnl.0000311269.57716.63"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_220","doi-asserted-by":"crossref","unstructured":"Walgrave, H., Balusu, S., Snoeck, S., Vanden Eynden, E., Craessaerts, K., Thrupp, N., Wolfs, L., Horr\u00e9, K., Fourne, Y., Ronisz, A., et al.. (2021). Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer\u2019s disease. Cell Stem Cell 28: 1805\u20131821.e1808, https:\/\/doi.org\/10.1016\/j.stem.2021.05.001.","DOI":"10.1016\/j.stem.2021.05.001"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_221","doi-asserted-by":"crossref","unstructured":"Wang, T., Zhou, J., Gan, X., Wang, H., Ding, X., Chen, L., Wang, Y., Du, J., Shen, J., and Yu, L. (2014). Toxoplasma gondii induce apoptosis of neural stem cells via endoplasmic reticulum stress pathway. Parasitology 141: 988\u2013995, https:\/\/doi.org\/10.1017\/s0031182014000183.","DOI":"10.1017\/S0031182014000183"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_222","doi-asserted-by":"crossref","unstructured":"Watson, A.M., Prasad, K.M., Klei, L., Wood, J.A., Yolken, R.H., Gur, R.C., Bradford, L.D., Calkins, M.E., Richard, J., Edwards, N., et al.. (2013). Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol. Med. 43: 1023\u20131031, https:\/\/doi.org\/10.1017\/s003329171200195x.","DOI":"10.1017\/S003329171200195X"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_223","doi-asserted-by":"crossref","unstructured":"Welcome, M.O. and Mastorakis, N.E. (2021). Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology 29: 939\u2013963, https:\/\/doi.org\/10.1007\/s10787-021-00806-x.","DOI":"10.1007\/s10787-021-00806-x"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_224","doi-asserted-by":"crossref","unstructured":"Westhoff, D., Engelen-Lee, J.Y., Hoogland, I.C.M., Aronica, E.M.A., van Westerloo, D.J., van de Beek, D., and van Gool, W.A. (2019). Systemic infection and microglia activation: a prospective postmortem study in sepsis patients. Immun. Ageing 16: 18, https:\/\/doi.org\/10.1186\/s12979-019-0158-7.","DOI":"10.1186\/s12979-019-0158-7"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_225","doi-asserted-by":"crossref","unstructured":"Westman, G., Berglund, D., Wid\u00e9n, J., Ingelsson, M., Korsgren, O., Lannfelt, L., Sehlin, D., Lidehall, A.K., and Eriksson, B.M. (2014). Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer\u2019s disease. PLoS One 9: e96779, https:\/\/doi.org\/10.1371\/journal.pone.0096779.","DOI":"10.1371\/journal.pone.0096779"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_226","doi-asserted-by":"crossref","unstructured":"Wozniak, M.A., Itzhaki, R.F., Shipley, S.J., and Dobson, C.B. (2007). Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci. Lett. 429: 95\u2013100, https:\/\/doi.org\/10.1016\/j.neulet.2007.09.077.","DOI":"10.1016\/j.neulet.2007.09.077"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_227","doi-asserted-by":"crossref","unstructured":"Wozniak, M.A., Frost, A.L., Preston, C.M., and Itzhaki, R.F. (2011). Antivirals reduce the formation of key Alzheimer\u2019s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One 6: e25152, https:\/\/doi.org\/10.1371\/journal.pone.0025152.","DOI":"10.1371\/journal.pone.0025152"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_228","doi-asserted-by":"crossref","unstructured":"Wu, Z. and Nakanishi, H. (2014). Connection between periodontitis and Alzheimer\u2019s disease: possible roles of microglia and leptomeningeal cells. J.\u00a0Pharmacol. Sci. 126: 8\u201313, https:\/\/doi.org\/10.1254\/jphs.14r11cp.","DOI":"10.1254\/jphs.14R11CP"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_229","doi-asserted-by":"crossref","unstructured":"Wu, Z., Ni, J., Liu, Y., Teeling, J.L., Takayama, F., Collcutt, A., Ibbett, P., and Nakanishi, H. (2017). Cathepsin B plays a critical role in inducing Alzheimer\u2019s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. Brain Behav. Immun. 65: 350\u2013361, https:\/\/doi.org\/10.1016\/j.bbi.2017.06.002.","DOI":"10.1016\/j.bbi.2017.06.002"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_230","doi-asserted-by":"crossref","unstructured":"Xia, X., Wang, Y., and Zheng, J. (2021). COVID-19 and Alzheimer\u2019s disease: how one crisis worsens the other. Transl. Neurodegener. 10: 15, https:\/\/doi.org\/10.1186\/s40035-021-00237-2.","DOI":"10.1186\/s40035-021-00237-2"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_231","doi-asserted-by":"crossref","unstructured":"Yamazaki, Y. and Kanekiyo, T. (2017). Blood-brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. Int. J.\u00a0Mol. Sci. 18: 1965, https:\/\/doi.org\/10.3390\/ijms18091965.","DOI":"10.3390\/ijms18091965"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_232","doi-asserted-by":"crossref","unstructured":"Yamazaki, Y., Shinohara, M., Shinohara, M., Yamazaki, A., Murray, M.E., Liesinger, A.M., Heckman, M.G., Lesser, E.R., Parisi, J.E., Petersen, R.C., et al.. (2019). Selective loss of cortical endothelial tight junction proteins during Alzheimer\u2019s disease progression. Brain 142: 1077\u20131092, https:\/\/doi.org\/10.1093\/brain\/awz011.","DOI":"10.1093\/brain\/awz011"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_233","doi-asserted-by":"crossref","unstructured":"Yang, S.H. (2019). Cellular and molecular mediators of neuroinflammation in alzheimer disease. Int. Neurourol. J. 23: S54\u2013S62, https:\/\/doi.org\/10.5213\/inj.1938184.092.","DOI":"10.5213\/inj.1938184.092"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_234","doi-asserted-by":"crossref","unstructured":"Yang, Q., Wang, G., and Zhang, F. (2020). Role of peripheral immune cells-mediated inflammation on the process of neurodegenerative diseases. Front. Immunol. 11: 582825, https:\/\/doi.org\/10.3389\/fimmu.2020.582825.","DOI":"10.3389\/fimmu.2020.582825"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_235","unstructured":"Yu, J.J., Lei, S., Li, F.L., Chen, S.S., and Tang, X.L. (2022). Effects of Porphyromonas gingivalis injected through tail vein on the expressions of biomarkers in neural stem cells and neurons of wild-type rats hippocampus. Zhonghua Kou Qiang Yi Xue Za Zhi 57: 375\u2013383, https:\/\/doi.org\/10.3760\/cma.j.cn112144-20220214-00059."},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_236","doi-asserted-by":"crossref","unstructured":"Zeng, F., Liu, Y., Huang, W., Qing, H., Kadowaki, T., Kashiwazaki, H., Ni, J., and Wu, Z. (2021). Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid \u03b2 accumulation after Porphyromonas gingivalis infection. J.\u00a0Neurochem. 158: 724\u2013736, https:\/\/doi.org\/10.1111\/jnc.15096.","DOI":"10.1111\/jnc.15096"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_237","doi-asserted-by":"crossref","unstructured":"Zhan, X., Stamova, B., Jin, L.W., DeCarli, C., Phinney, B., and Sharp, F.R. (2016). Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87: 2324\u20132332, https:\/\/doi.org\/10.1212\/wnl.0000000000003391.","DOI":"10.1212\/WNL.0000000000003391"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_238","doi-asserted-by":"crossref","unstructured":"Zhang, J., Yu, C., Zhang, X., Chen, H., Dong, J., Lu, W., Song, Z., and Zhou, W. (2018). Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL\/6 mice. J.\u00a0Neuroinflammation 15: 37, https:\/\/doi.org\/10.1186\/s12974-017-1052-x.","DOI":"10.1186\/s12974-017-1052-x"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_239","doi-asserted-by":"crossref","unstructured":"Zhang, B.Z., Chu, H., Han, S., Shuai, H., Deng, J., Hu, Y.F., Gong, H.R., Lee, A.C., Zou, Z., Yau, T., et al.. (2020). SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 30: 928\u2013931, https:\/\/doi.org\/10.1038\/s41422-020-0390-x.","DOI":"10.1038\/s41422-020-0390-x"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_240","doi-asserted-by":"crossref","unstructured":"Zhang, B., Wang, H.E., Bai, Y.M., Tsai, S.J., Su, T.P., Chen, T.J., Wang, Y.P., and Chen, M.H. (2021a). Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut 70: 85\u201391, https:\/\/doi.org\/10.1136\/gutjnl-2020-320789.","DOI":"10.1136\/gutjnl-2020-320789"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_241","doi-asserted-by":"crossref","unstructured":"Zhang, N., Zuo, Y., Jiang, L., Peng, Y., Huang, X., and Zuo, L. (2021b). Epstein-barr virus and neurological diseases. Front. Mol. Biosci. 8: 816098, https:\/\/doi.org\/10.3389\/fmolb.2021.816098.","DOI":"10.3389\/fmolb.2021.816098"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_242","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Na, H., Gan, Q., Tao, Q., Alekseyev, Y., Hu, J., Yan, Z., Yang, J.B., Tian, H., Zhu, S., et al.. (2021c). Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: a risk factor for Alzheimer\u2019s disease? Aging Cell 20: e13501, https:\/\/doi.org\/10.1111\/acel.13501.","DOI":"10.1111\/acel.13501"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_243","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Gan, Q., Han, J., Tao, Q., Qiu, W.Q., and Madri, J.A. (2023). CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer\u2019s disease. J.\u00a0Cereb. Blood Flow Metab. 43: 1027\u20131041, https:\/\/doi.org\/10.1177\/0271678x231170041.","DOI":"10.1177\/0271678X231170041"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_244","doi-asserted-by":"crossref","unstructured":"Zhao, Y. and Lukiw, W.J. (2022). SARS-CoV-2 neuroinvasion, inflammatory neurodegeneration and Alzheimer\u2019s disease. Front. Cell. Neurosci. 16: 937961, https:\/\/doi.org\/10.3389\/fncel.2022.937961.","DOI":"10.3389\/fncel.2022.937961"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_245","doi-asserted-by":"crossref","unstructured":"Zheng, W., Klammer, A.M., Naciri, J.N., Yeung, J., Demers, M., Milosevic, J., Kinchington, P.R., Bloom, D.C., Nimgaonkar, V.L., and D\u2019Aiuto, L. (2020). Patterns of herpes simplex virus 1 infection in neural progenitor cells. J.\u00a0Virol. 94: e00994\u2013e009920, https:\/\/doi.org\/10.1128\/jvi.00994-20.","DOI":"10.1128\/JVI.00994-20"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_246","doi-asserted-by":"crossref","unstructured":"Zhu, L., Yuan, Q., Zeng, Z., Zhou, R., Luo, R., Zhang, J., Tsang, C.K., and Bi, W. (2021). Rifampicin suppresses amyloid-\u03b2 accumulation through enhancing autophagy in the hippocampus of a lipopolysaccharide-induced mouse model of cognitive decline. J.\u00a0Alzheimer\u2019s Dis. 79: 1171\u20131184, https:\/\/doi.org\/10.3233\/jad-200690.","DOI":"10.3233\/JAD-200690"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_247","doi-asserted-by":"crossref","unstructured":"Zlokovic, B.V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12: 723\u2013738, https:\/\/doi.org\/10.1038\/nrn3114.","DOI":"10.1038\/nrn3114"},{"key":"2024080910403062789_j_revneuro-2023-0049_ref_248","doi-asserted-by":"crossref","unstructured":"Zotova, N.V., Chereshnev, V.A., and Gusev, E.Y. (2016). Systemic inflammation: methodological approaches to identification of the common pathological process. PLoS One 11: e0155138, https:\/\/doi.org\/10.1371\/journal.pone.0155138.","DOI":"10.1371\/journal.pone.0155138"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2023-0049\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2023-0049\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:45:00Z","timestamp":1723200300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2023-0049\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":248,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2024,1,29]]}},"alternative-id":["10.1515\/revneuro-2023-0049"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2023-0049","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]}}}